image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
9b59ebfe9f86c270a59ec9298dd44fc2796037411ae0d8076c6690e13bd0dc0b.png | complex | <table><tr><td></td><td colspan="3">Cohort 1* - ELISA studies</td><td colspan="3">Cohort 2** - proteomic studies</td></tr><tr><td>Characteristics</td><td>CIS → CIS</td><td>CIS → CDMS</td><td><i>P</i>values</td><td>CIS → CIS</td><td>CIS → CDMS</td><td><i>P</i>values</td></tr><tr><td>n</td><td>27<... | <table><tr><td></td></tr><tr><td>Characteristics</td></tr><tr><td>n</td></tr><tr><td>Age (years)a</td></tr><tr><td>Female/male (% female)</td></tr><tr><td>Follow-up time (years)a</td></tr><tr><td>Clinical presentation</td></tr><tr><td>Optic neuritis</td></tr><tr><td>Brainstem</td></tr><tr><td>Spinal</td></tr><tr><td>Ot... | <table><tr><td colspan="3">Cohort 1* - ELISA studies</td><td colspan="3">Cohort 2** - proteomic studies</td></tr><tr><td>CIS → CIS</td><td>CIS → CDMS</td><td>Pvalues</td><td>CIS → CIS</td><td>CIS → CDMS</td><td>Pvalues</td></tr><tr><td>27</td><td>29</td><td>-</td><td>18</td><td>18</td><td>-</td></tr><tr><td>28.1 (9.6)<... |
cc805f388fed30ba3dc12402ab4be797ad25728c85fddbb77657e6478cd44655.png | simple | <table><tr><td>Variable</td><td>Definition</td></tr><tr><td>Taxonomic class</td><td>Within this example we adopt the designation of taxonomic Specification from the NCBI's taxonomy database [63].</td></tr><tr><td>Injection.chemical</td><td>The chemical molecule injected into the brain of an animal as part of a tract-tr... | <table><tr><td>Variable</td><td>Definition</td></tr><tr><td>Taxonomic class</td><td>Within this example we adopt the designation of taxonomic Specification from the NCBI's taxonomy database [63].</td></tr><tr><td>Injection.chemical</td><td>The chemical molecule injected into the brain of an animal as part of a tract-tr... | <table><tr><td>Injection.location</td><td>This refers to the extent of the complete injection site expressed in terms of its spatial relationships to identified brain structures from the Swanson atlas [32] and encoded into the neuroanatomical nomenclature specified from the BAMS system [72]</td></tr><tr><td>Mapped loca... |
79dafe82091bb754076e78d3d05ac359ec8305435589d854c705841993d9483d.png | simple | <table><tr><td></td><td>Preoperative model</td><td>Postoperative model</td><td>Intra-ICU model</td></tr><tr><td>(Constant)</td><td>1.26</td><td>0.44</td><td>1.82</td></tr><tr><td>Expected session time (min)</td><td>1.10 (1.01–1.21)</td><td></td><td></td></tr><tr><td>Patient age (per decade)</td><td>1.16 (1.06R... | <table><tr><td></td><td>Preoperative model</td><td>Postoperative model</td><td>Intra-ICU model</td></tr><tr><td>(Constant)</td><td>1.26</td><td>0.44</td><td>1.82</td></tr><tr><td>Expected session time (min)</td><td>1.10 (1.01–1.21)</td><td></td><td></td></tr><tr><td>Patient age (per decade)</td><td>1.16 (1.06–1.28)</td... | <table><tr><td></td><td>Preoperative model</td><td>Postoperative model</td><td>Intra-ICU model</td></tr><tr><td> (yes/no)</td><td>)</td><td>1.53 (1.19–1.96)</td><td></td></tr><tr><td>Vascular comorbidity (yes/no)</td><td>1.29 (1.01–1.66)</td><td>1.32 (1.03–1.69)</td><td></td></tr><tr><td>Neurological comorbidity (yes/n... |
fcde257c6b92eb3365bedc3f9ece46dc1aa525f86408b47978e4d47c5f9eecd7.png | simple | <table><tr><td>Variable, n (%)</td><td>n=841*</td></tr><tr><td>Gender (female) n=821*</td><td>689 (83.9)</td></tr><tr><td>Age: n= 819*</td><td> </td></tr><tr><td>>−25</td><td>88 (10.7)</td></tr><tr><td>25-35</td><td>172 (21.0)</td></tr><tr><td>35-45</td><td>215 (26.3)</td></tr><tr><td>45-55</td><td>205 (25.0)<... | <table><tr><td>Variable, n (%)</td></tr><tr><td>Gender (female) n=821*</td></tr><tr><td>Age: n= 819*</td></tr><tr><td>>−25</td></tr><tr><td>25-35</td></tr><tr><td>35-45</td></tr><tr><td>45-55</td></tr><tr><td>55-<</td></tr><tr><td>Born not in Sweden, n=819*</td></tr><tr><td>Profession: n=798*</td></tr><tr><td>Health ca... | <table><tr><td>n=841*</td></tr><tr><td>689 (83.9)</td></tr><tr><td></td></tr><tr><td>88 (10.7)</td></tr><tr><td>172 (21.0)</td></tr><tr><td>215 (26.3)</td></tr><tr><td>205 (25.0)</td></tr><tr><td>139 (17.0)</td></tr><tr><td>389 (47.5)</td></tr><tr><td></td></tr><tr><td>678 (85.0)</td></tr><tr><td>49 (6.1)</td></tr><tr>... |
3b92798d3212ab62ae1394307a205b1ca7abd539ce5618208f51c035a9395050.png | simple | <table><tr><td>Concentration</td><td>EAC Control</td><td>PST 200 mg/kg</td><td>5-FU 20 mg/kg</td><td>PST + 5-FU</td></tr><tr><td>Tumor volume (mL)</td><td>9.7 ± 0.2</td><td>4.4 ± 0.34***</td><td>3.3 ± 0.6***</td><td>2.9 ± 0.29***</td></tr><tr><td> Body weight (g)</td><td>34.91 ± 1.9</td><td>30.... | <table><tr><td>Concentration</td><td>EAC Control</td><td>PST 200 mg/kg</td><td>5-FU 20 mg/kg</td><td>PST + 5-FU</td></tr><tr><td>Tumor volume (mL)</td><td>9.7 ± 0.2</td><td>4.4 ± 0.34***</td><td>3.3 ± 0.6***</td><td>2.9 ± 0.29***</td></tr></table> | <table><tr><td>Body weight (g)</td><td>34.91 ± 1.9</td><td>30.8 ± 1.2**</td><td>26.21 ± 2.3**</td><td>25.12 ± 2.7**</td></tr><tr><td>PCV (mL)</td><td>3 ± 0.45</td><td>1.2 ± 0.1***</td><td>0.8 ± 0.1***</td><td>0.6 ± 0.2***</td></tr><tr><td>Mean survival time (Days)</td><td>20 ± 1</td><td>33 ± 2***</td><td>44 ± 0.57***</... |
7e02c30d84ac8d55062214087321ee6b879607a733c9ecd1871f99235463fbcf.png | simple | <table><tr><td>Comparison</td><td>CYP19A1 vs. RORA*</td><td>A2BP1 vs. RORA</td><td>ITPR1 vs. RORA</td><td>NLGN1 vs. RORA</td></tr><tr><td>Correlation coefficient</td><td>0.99</td><td>0.83</td><td>0.72</td><td>0.81</td></tr><tr><td><i>P</i> val (2-tailed)</td><td>0.03</td><td>0.38</td><td>0.49</td><td>0.39</td></tr><tr>... | <table><tr><td>Comparison</td><td>CYP19A1 vs. RORA*</td></tr><tr><td>Correlation coefficient</td><td>0.99</td></tr><tr><td>P val (2-tailed)</td><td>0.03</td></tr><tr><td>R2</td><td>0.99</td></tr></table> | <table><tr><td>A2BP1 vs. RORA</td><td>ITPR1 vs. RORA</td><td>NLGN1 vs. RORA</td></tr><tr><td>0.83</td><td>0.72</td><td>0.81</td></tr><tr><td>0.38</td><td>0.49</td><td>0.39</td></tr><tr><td>0.69</td><td>0.52</td><td>0.66</td></tr></table> |
af5538f8e06f9c099ed51cc948859f5d34c0fe2298a48506f8d78e51cf9f8320.png | complex | <table><tr><td>Characteristic</td><td>N (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Male</td><td>58 (61.1)</td></tr><tr><td>Female</td><td>36 (38.8)</td></tr><tr><td>Missing</td><td>1 (1.1)</td></tr><tr><td colspan="2">Work-place</td></tr><tr><td>Ministry of Health</td><td>15 (15.7)</td></tr><tr><td>Tertiary/... | <table><tr><td>Characteristic</td><td>N (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Male</td><td>58 (61.1)</td></tr></table> | <table><tr><td>Female</td><td>36 (38.8)</td></tr><tr><td>Missing</td><td>1 (1.1)</td></tr><tr><td colspan="2">Work-place</td></tr><tr><td>Ministry of Health</td><td>15 (15.7)</td></tr><tr><td>Tertiary/referral hospital</td><td>32 (33.7)</td></tr><tr><td>University</td><td>27 (28.4)</td></tr><tr><td>NGO</td><td>20 (21.1... |
c2b75a0e5ddc8374e1ee44be364e486f3f8f88b982ec6747ce1360a7a253182c.png | simple | <table><tr><td> </td><td>RA-UIP</td><td>IPF</td><td>Controls</td><td>p-value</td></tr><tr><td>Telomere length</td><td>0.663(1.476, 11.548)</td><td>1.118 (0.747, 9.867)</td><td>1.876 (0.038, 3.221)</td><td>0.170</td></tr></table> | <table><tr><td></td></tr><tr><td>Telomere length</td></tr></table> | <table><tr><td>RA-UIP</td><td>IPF</td><td>Controls</td><td>p-value</td></tr><tr><td>0.663(1.476, 11.548)</td><td>1.118 (0.747, 9.867)</td><td>1.876 (0.038, 3.221)</td><td>0.170</td></tr></table> |
ea908f5d1a9ce9cf1b654f7f2d82efbf7b1e82679e906d757f0c66fe282d21b5.png | simple | <table><tr><td>Risk Factors</td><td>Odds Ratio for Anti-HEV IgM, 95% CI</td><td><i>P</i> value<sup>†</sup></td><td>Odds Ratio for Anti-HEV IgG, 95% CI</td><td><i>P</i> value<sup>γ</sup></td></tr><tr><td>CD4+ count >200cells/μl</td><td>5.109 [1.624–16.070]</td><td>0.005*</td><td>0.67 [.333–... | <table><tr><td>Risk Factors</td><td>Odds Ratio for Anti-HEV IgM, 95% CI</td><td>P value†</td><td>Odds Ratio for Anti-HEV IgG, 95% CI</td><td>P valueγ</td></tr><tr><td>CD4+ count >200cells/μl</td><td>5.109 [1.624–16.070]</td><td>0.005*</td><td>0.67 [.333–1.36]</td><td>0.273</td></tr></table> | <table><tr><td>Risk Factors</td><td>Odds Ratio for Anti-HEV IgM, 95% CI</td><td>P value†</td><td>Odds Ratio for Anti-HEV IgG, 95% CI</td><td>P valueγ</td></tr><tr><td>Anti HCV Positive status</td><td>0.018 [0.006–0.056]</td><td><0.001*</td><td>5.35 [2.44–11.69]</td><td><0.001*</td></tr><tr><td>Residing in Kathmandu Val... |
55f68c9fc2a36c149ff5709c4fa82cdba5fa9e9499c006bd6d0aabd2d70e5341.png | simple | <table><tr><td><i>ID #</i></td><td><i>Age (yr)</i></td><td><i>Sex</i></td><td><i>RBT (w)</i></td><td><i>Symptoms</i></td><td><i>HP</i></td><td><i>ED</i></td><td><i>GH</i></td><td><i>PU</i></td><td><i>AD</i></td><td><i>RD</i></td></tr><tr><td>1</td><td>5.9</td><td>M</td><td>4</td><td></td><td></td><td></td><td></td><td>... | <table><tr><td>ID #</td><td>Age (yr)</td><td>Sex</td><td>RBT (w)</td><td>Symptoms</td><td>HP</td><td>ED</td><td>GH</td><td>PU</td><td>AD</td><td>RD</td></tr></table> | <table><tr><td>1</td><td>5.9</td><td>M</td><td>4</td><td></td><td></td><td></td><td></td><td>Severe</td><td></td><td></td></tr><tr><td>2</td><td>13.4</td><td>M</td><td>3</td><td>Arthralgia</td><td></td><td></td><td></td><td>Mild</td><td></td><td></td></tr><tr><td>3</td><td>5.4</td><td>M</td><td>6</td><td></td><td>+</td... |
28d685de80356d40969a60eb9b5ffdde865ad3e57a584a3fb0aee772b709b78f.png | complex | <table><tr><td colspan="2">Demographic category</td><td>N (%)</td></tr><tr><td colspan="2"><i>N</i></td><td>1184</td></tr><tr><td colspan="2"><i>Age (m,sd)</i></td><td>66.6 (10.8)</td></tr><tr><td colspan="2"><i>Age</i></td><td> </td></tr><tr><td colspan="2">18-45</td><td>45 (3.8)</td></tr><tr><td colspan="2">46-60</td... | <table><tr><td colspan="2">Demographic category</td><td>N (%)</td></tr><tr><td colspan="2">N</td><td>1184</td></tr><tr><td colspan="2">Age (m,sd)</td><td>66.6 (10.8)</td></tr><tr><td colspan="2">Age</td><td></td></tr><tr><td colspan="2">18-45</td><td>45 (3.8)</td></tr><tr><td colspan="2">46-60</td><td>281 (23.7)</td></... | <table><tr><td>Other health complications</td><td>None</td><td>216 (18.5)</td></tr><tr><td colspan="2">One or more</td><td>952 (81.5)</td></tr><tr><td colspan="2">Arthritis</td><td>503 (43.2)</td></tr><tr><td colspan="2">Hypertension</td><td>513 (44.1)</td></tr><tr><td colspan="2">High cholesterol</td><td>588 (50.5)</t... |
509b9a079e3e1231b869538b0e737321e1106372a725128c8b90ab93d1525dd6.png | complex | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td colspan="2">General assumptions for the facility</td></tr><tr><td>rBuChE production level </td><td>25 kg rBuChE/year (bulk)</td></tr><tr><td>rBuChE doses per year</td><td>62,500 doses/year at 400 mg/dose</td></tr><tr><td>Downstream Recovery/purification yield</td>... | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td colspan="2">General assumptions for the facility</td></tr><tr><td>rBuChE production level</td><td>25 kg rBuChE/year (bulk)</td></tr><tr><td>rBuChE doses per year</td><td>62,500 doses/year at 400 mg/dose</td></tr><tr><td>Downstream Recovery/purification yield</td><... | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Dilution factor between agroinfiltration solution and agrobacterial production fermentor</td><td>78</td></tr><tr><td>Percent weight change in plant tissue following vacuum agroinfiltration</td><td>30%</td></tr><tr><td>Trays processed per vacuum chamber (30 ft) per... |
28f5486beb4f5dbe37d3f68cbf4934ebe12b2bfd6fb6d271ee758b7fe7a275ed.png | complex | <table><tr><td> </td><td>Overall</td><td colspan="3">Ability to access to NSP syringes<sup>‡</sup></td><td>χ<sup>2</sup>-test</td><td colspan="3">Venue stratification</td><td>χ<sup>2</sup>-test</td></tr><tr><td> </td><td> </td><td><40%</td><td>40-70%</td><td>>70%</td><td>(χ<sup>2</sup>, <i>p<... | <table><tr><td></td><td>Overall</td><td colspan="3">Ability to access to NSP syringes‡</td><td>χ2-test</td><td colspan="3">Venue stratification</td><td>χ2-test</td></tr><tr><td></td><td></td><td><40%</td><td>40-70%</td><td>>70%</td><td>(χ2, p-value)</td><td>MDC</td><td>Community</td><td>NSP</td><td>(χ2, p value)</td></... | <table><tr><td></td><td>Overall</td><td colspan="3">Ability to access to NSP syringes‡</td><td>χ2-test</td><td colspan="3">Venue stratification</td><td>χ2-test</td></tr><tr><td></td><td></td><td><40%</td><td>40-70%</td><td>>70%</td><td>(χ2, p-value)</td><td>MDC</td><td>Community</td><td>NSP</td><td>(χ2, p value)</td></... |
1d0da38fa8ed4bb2af7166d5439f9faafcff1851c005892414764c6e34f78dd5.png | simple | <table><tr><td>Feature</td><td>Restenosis group (<i>n</i> = 74)</td><td>Non-restenosis group (<i>n</i> = 91)</td><td><i>P</i></td></tr><tr><td>Age (years)</td><td>65.4 ± 8.6</td><td>64.7 ± 8.0</td><td>0.583</td></tr><tr><td>Male, n (%)</td><td>52 (70.2)</td><td>60 (65.9)</td><td>0.553</td></tr><tr><td>BMI (kg... | <table><tr><td>Feature</td><td>Restenosis group (n = 74)</td><td>Non-restenosis group (n = 91)</td></tr><tr><td>Age (years)</td><td>65.4 ± 8.6</td><td>64.7 ± 8.0</td></tr><tr><td>Male, n (%)</td><td>52 (70.2)</td><td>60 (65.9)</td></tr><tr><td>BMI (kg/m2)</td><td>24.8 ± 3.6</td><td>24.1 ± 3.2</td></tr><tr><td>Hypertens... | <table><tr><td>P</td></tr><tr><td>0.583</td></tr><tr><td>0.553</td></tr><tr><td>0.184</td></tr><tr><td>0.825</td></tr><tr><td>0.797</td></tr><tr><td>0.785</td></tr><tr><td><0.001</td></tr><tr><td><0.001</td></tr><tr><td>0.935</td></tr><tr><td>0.221</td></tr><tr><td>0.558</td></tr><tr><td>0.177</td></tr><tr><td><0.001</... |
47eedd638e9a585e91b228d6842abe9d33a28d4ffde920d9904063deddaf591e.png | simple | <table><tr><td></td><td>With SD (n = 165)</td><td>Without SD (n = 35)</td><td>P</td></tr><tr><td></td><td>No (%)</td><td>No (%)</td><td></td></tr><tr><td>Gender (n = 200)</td><td></td><td></td><td>0.04</td></tr><tr><td>Women (n = 100)</td><td>88 (88.0)</td><td>12 (12.0)</td><td></td></tr><tr><td>Men (n = 100)</td><td>7... | <table><tr><td></td><td>With SD (n = 165)</td><td>Without SD (n = 35)</td><td>P</td></tr><tr><td></td><td>No (%)</td><td>No (%)</td><td></td></tr><tr><td>Gender (n = 200)</td><td></td><td></td><td>0.04</td></tr><tr><td>Women (n = 100)</td><td>88 (88.0)</td><td>12 (12.0)</td><td></td></tr><tr><td>Men (n = 100)</td><td>7... | <table><tr><td>Controlled</td><td>80(80.0)</td><td>20(20.0)</td><td></td></tr><tr><td>Uncontrolled</td><td>85(85.0)</td><td>15(15.0)</td><td></td></tr><tr><td>Duration of diabetes (years)</td><td></td><td></td><td>0.64</td></tr><tr><td>10-14</td><td>130(81.2)</td><td>30(18.8)</td><td></td></tr><tr><td>15-19</td><td>27(... |
69394e9c10d41c487bc8341b9e43a56e99b0c2239b96237efefadb8edd7e4bde.png | simple | <table><tr><td></td><td>Value</td><td>Alternative Indicator</td></tr><tr><td>Waist circumference</td><td>* >94 cm in males, >80 cm in females** >102 cm in males, >88 cm in females</td><td></td></tr><tr><td>Raised blood pressure</td><td>Systolic ≥130 and/or diastolic ≥85 mm Hg</td><td>Treatment o... | <table><tr><td></td></tr><tr><td>Waist circumference</td></tr><tr><td>Raised blood pressure</td></tr><tr><td>Raised FPG</td></tr><tr><td>Raised TG</td></tr><tr><td>Reduced HDL-C</td></tr></table> | <table><tr><td>Value</td><td>Alternative Indicator</td></tr><tr><td>* >94 cm in males, >80 cm in females** >102 cm in males, >88 cm in females</td><td></td></tr><tr><td>Systolic ≥130 and/or diastolic ≥85 mm Hg</td><td>Treatment of previously diagnosed hypertension</td></tr><tr><td>≥100 mg/dL (5.6 mmol/L)</td><td>Previo... |
fcd47c531dda31a37cb1a01ab9f871a7db5d31a2d1a036c11fc0dad8f4b818d3.png | simple | <table><tr><td>Probe Set</td><td>z-score</td><td>DMFS</td><td>Gene Symbol</td><td>Gene Title</td></tr><tr><td>208905_at</td><td>4.29</td><td>-</td><td>CYCS</td><td>cytochrome c, somatic</td></tr><tr><td>204817_at</td><td>3.73</td><td>-</td><td>ESPL1</td><td>extra spindle poles like 1</td></tr><tr><td>38158_at</td><td>3... | <table><tr><td>P</td><td>z-</td><td>D</td><td>Gene</td><td>Gene</td></tr></table> | <table><tr><td>robe Set</td><td>score</td><td>MFS</td><td> Symbol</td><td> Title</td></tr><tr><td>208905_at</td><td>4.29</td><td>-</td><td>CYCS</td><td>cytochrome c, somatic</td></tr><tr><td>204817_at</td><td>3.73</td><td>-</td><td>ESPL1</td><td>extra spindle poles like 1</td></tr><tr><td>38158_at</td><td>3.41</td><td>... |
c4145e619e195616d7c6febb6a55d4199e867d03e4d4935586d89106d50b1623.png | simple | <table><tr><td></td><td>Connecticut (n = 631 visits) %</td><td>Washington (n = 1186 visits) %</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td> female</td><td>76</td><td>74</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td> Median</td><td>43 years</td><td>42 years</td></tr><tr><td> 0–15 years</td>... | <table><tr><td></td><td>Connecticut (n = 631 visits) %</td><td>Washington (n = 1186 visits) %</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>female</td><td>76</td><td>74</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td>Median</td><td>43 years</td><td>42 years</td></tr><tr><td>0–15 years</td><td>12.8<... | <table><tr><td></td><td>Connecticut (n = 631 visits) %</td><td>Washington (n = 1186 visits) %</td></tr><tr><td>16–34 years</td><td>16.4</td><td>20.9</td></tr><tr><td>35–64 years</td><td>63.0</td><td>58.5</td></tr><tr><td>65 years+</td><td>7.8</td><td>9.7</td></tr><tr><td>Race</td><td></td><td></td></tr><tr><td>White</t... |
e1bfc751d4dea106864d43fe1704093bb68ffcb18f09a74c7109c7d15ef0b9a1.png | simple | <table><tr><td>Scopus</td><td>Query</td><td>Research in:</td><td>Items found</td></tr><tr><td>#1</td><td>“Sensory integration” OR “multisensory integration” OR “crossmodal integration” OR “cross-modal integration” OR “intersensory integration” OR “multim... | <table><tr><td>Scopus</td><td>Query</td><td>Research in:</td><td>Items found</td></tr><tr><td>#1</td><td>“Sensory integration” OR “multisensory integration” OR “crossmodal integration” OR “cross-modal integration” OR “intersensory integration” OR “multimodal integration” OR “crossmodal illusion*” OR “cross-modal illusi... | <table><tr><td>Scopus</td><td>Query</td><td>Research in:</td><td>Items found</td></tr><tr><td>#6</td><td>Exclude (“Speech perception”, “Speech Perception”, “Speech”)</td><td></td><td>351</td></tr><tr><td>#7</td><td>Exclude (“Alzheimer Disease”, “Alzheimer disease”, “Parkinson Disease”, “Parkinson disease”, “Aphasia”, “... |
38f717e25ed2cf4c9e67361dd1e8916a2b42fae69be3eb88329b1b93c2b9f63f.png | complex | <table><tr><td>Therapeutic Strategy</td><td>Gene/System</td><td>Strong Points</td><td>Weak Points</td></tr><tr><td rowspan="2">Tumor Suppressor gene</td><td><i>p53</i></td><td>Altered gene in a high percentage of OC.The use of Gendicine (a recombinant human Ad-p53) has been approved in the treatment of OC in China. Sev... | <table><tr><td>Therapeutic Strategy</td><td>Gene/System</td><td>Strong Points</td><td>Weak Points</td></tr><tr><td rowspan="2">Tumor Suppressor gene</td><td>p53</td><td>Altered gene in a high percentage of OC.The use of Gendicine (a recombinant human Ad-p53) has been approved in the treatment of OC in China. Several cl... | <table><tr><td>Therapeutic Strategy</td><td>Gene/System</td><td>Strong Points</td><td>Weak Points</td></tr><tr><td></td><td>VSV</td><td>therapeutic genes.A phase I trial is currently ongoing.</td><td>sponse intact in most OC cells, blocking virus replication.</td></tr></table> |
69efdeace0f8923c2e247b7ef9db5c271c07b0230a864b94e0afb11b0d2abe6d.png | simple | <table><tr><td>RGB Only</td><td>NIR Only</td><td>Early Fusion</td><td>Late Fusion</td></tr><tr><td>0.816</td><td>0.797</td><td>0.799</td><td>0.838</td></tr></table> | <table><tr><td>RGB Only</td><td>NIR Only</td><td>Early Fusion</td><td>Late Fusion</td></tr></table> | <table><tr><td>0.816</td><td>0.797</td><td>0.799</td><td>0.838</td></tr></table> |
7f5492d22de3bf1389bc6ad2c91f5566ba0b2485ff60347e705afb242a476fd4.png | complex | <table><tr><td rowspan="2" colspan="2">Physical activity in leisure time (hours per week)</td><td rowspan="2"></td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td>Adjustment for age</td><td>Additional adjustment<sup>a</sup></td><td>Adjustment for age</td><td>Additional adjustment<sup>a</sup></td></tr><tr... | <table><tr><td rowspan="2" colspan="2">Physical activity in leisure time (hours per week)</td><td rowspan="2"></td><td colspan="2">Women</td><td colspan="2">Men</td></tr><tr><td>Adjustment for age</td><td>Additional adjustmenta</td><td>Adjustment for age</td><td>Additional adjustmenta</td></tr><tr><td colspan="2"></td>... | <table><tr><td><1</td><td>0</td><td>1</td><td>1.00 (reference)</td><td>1.00 (reference)</td><td>1.00 (reference)</td><td>1.00 (reference)</td></tr><tr><td>≥1</td><td>0</td><td>2</td><td>0.94 (0.83–1.05)</td><td>0.97 (0.86–1.09)</td><td>0.96 (0.82–1.13)</td><td>1.03 (0.87–1.21)</td></tr><tr><td></td><td><1b</td><td>3</t... |
a745fd450fa951612865d068f9ee91554b4ec3e93ead84e03141709e5632b762.png | simple | <table><tr><td>Material</td><td><i>E</i><sup>1/3</sup>/<i>ρ</i> (GPa<sup>1/3</sup>/(Mg/m<sup>3</sup>))</td><td><i>η</i></td></tr><tr><td>Cast iron</td><td>0.63</td><td>1.2 × 10<sup>−3</sup>–1.7 × 10<sup>−3</sup></td></tr><tr><td>Steel</td><td>0.77</td><td>6.0 × 10<sup>−4... | <table><tr><td>Material</td><td>E1/3/ρ (GPa1/3/(Mg/m3))</td><td>η</td></tr><tr><td>Cast iron</td><td>0.63</td><td>1.2 × 10−3–1.7 × 10−3</td></tr></table> | <table><tr><td>Material</td><td>E1/3/ρ (GPa1/3/(Mg/m3))</td><td>η</td></tr><tr><td>Steel</td><td>0.77</td><td>6.0 × 10−4–1.0 × 10−3</td></tr><tr><td>Al alloys</td><td>1.50</td><td>2.0 × 10−4–4.0 × 10−4</td></tr><tr><td>Mg alloys</td><td>1.90</td><td>1.0 × 10−3–1.0 × 10−2</td></tr><tr><td>Al corrugated sandwich</td><td>... |
c65ebf8c337e0486a864fa1ea1fc968b60ff4b62e44b85a4a2af0932623d262f.png | complex | <table><tr><td></td><td colspan="6">Lactate (μm)</td></tr><tr><td></td><td colspan="3">d-Lactate</td><td colspan="3">l-lactate</td></tr><tr><td>Cell line</td><td>Plus methylglyoxal</td><td>Minus methylglyoxal</td><td>Net</td><td>Plus methylglyoxal</td><td>Minus methylglyoxal</td><td>Net</td></tr><tr><td colspan="7... | <table><tr><td></td><td colspan="5">Lactate (μm)</td></tr><tr><td></td><td colspan="3">d-Lactate</td><td colspan="2">l-lactate</td></tr><tr><td>Cell line</td><td>Plus methylglyoxal</td><td>Minus methylglyoxal</td><td>Net</td><td>Plus methylglyoxal</td><td>Minus methylglyoxal</td></tr><tr><td colspan="6">T. brucei</td><... | <table><tr><td>Lactate (μm)</td></tr><tr><td>l-lactate</td></tr><tr><td>Net</td></tr><tr><td>T. brucei</td></tr><tr><td>124</td></tr><tr><td>221</td></tr><tr><td>pLew100–luciferase</td></tr><tr><td>115</td></tr><tr><td>211</td></tr><tr><td>pLew100–TcGLO1</td></tr><tr><td>100</td></tr><tr><td>203</td></tr></table> |
3a5d3a40978d02331ce86e1204c1e73c4695937fbebc3972bd22a02c34deb0bf.png | simple | <table><tr><td>Characteristics</td><td>Study group (N= 19)</td><td>Control group (N= 19)</td><td>p-value</td></tr><tr><td>Fertilization rate</td><td>95.33%</td><td>84.4%</td><td>0.11</td></tr><tr><td>cleavage rate</td><td>89.56%</td><td>87.74%</td><td>0.76</td></tr><tr><td>Implantation rate</td><td>17.64%</td><td>7.4%<... | <table><tr><td>Characteristics</td><td>Study group (N= 19)</td><td>Control group (N= 19)</td><td>p-value</td></tr><tr><td>Fertilization rate</td><td>95.33%</td><td>84.4%</td><td>0.11</td></tr></table> | <table><tr><td>cleavage rate</td><td>89.56%</td><td>87.74%</td><td>0.76</td></tr><tr><td>Implantation rate</td><td>17.64%</td><td>7.4%</td><td>0.14</td></tr><tr><td>Chemical pregnancy rate/cycle [n (%)]</td><td>8 (47.1%)</td><td>3 (16.7%)</td><td>0.07</td></tr><tr><td>Clinical pregnancy rate/cycle [n (%)]</td><td>7 (41... |
6918aa5a82dc792efdfad299daf756e956cdb4a33e9dac8e8096357549aa5826.png | simple | <table><tr><td> </td><td>Brightness</td><td>Contrast</td><td>Entropy</td><td>Clarity</td></tr><tr><td>Original image</td><td>57.15</td><td>311.36</td><td>6.29</td><td>38.21</td></tr><tr><td>IEABPM</td><td>77.42</td><td>441.67</td><td>10.18</td><td>59.83</td></tr><tr><td>IIEABPM</td><td>79.26</td><td>487.82</td><td>14.0... | <table><tr><td></td><td>Brightness</td><td>Contrast</td><td>Entropy</td><td>Clarity</td></tr><tr><td>Or</td><td>57</td><td>31</td><td>6.29</td><td>38.</td></tr></table> | <table><tr><td>iginal image</td><td>.15</td><td>1.36</td><td></td><td>21</td></tr><tr><td>IEABPM</td><td>77.42</td><td>441.67</td><td>10.18</td><td>59.83</td></tr><tr><td>IIEABPM</td><td>79.26</td><td>487.82</td><td>14.01</td><td>73.85</td></tr></table> |
b8a8b49c3b01d34bb4880149fed1558712d59cef87f6c4a9b2a8df557c281790.png | complex | <table><tr><td></td><td colspan="2">Sex (n)</td><td colspan="2">Age (years)</td><td colspan="2">Side (n)</td></tr><tr><td></td><td>Female</td><td>Male</td><td>Median</td><td>Range</td><td>Right</td><td>Left</td></tr><tr><td>total</td><td>8</td><td>8</td><td>34</td><td>20–76</td><td>11</td><td>5</td></tr></table> | <table><tr><td></td><td colspan="2">Se</td><td colspan="2">Age (yea</td><td colspan="2">Si</td></tr></table> | <table><tr><td></td><td colspan="2">x (n)</td><td colspan="2">rs)</td><td colspan="2">de (n)</td></tr><tr><td></td><td>Female</td><td>Male</td><td>Median</td><td>Range</td><td>Right</td><td>Left</td></tr><tr><td>total</td><td>8</td><td>8</td><td>34</td><td>20–76</td><td>11</td><td>5</td></tr></table> |
ccbb20ea4422e097df276795f7c1d7d45e0d9d79df81b175ebd6cab8e7e00bf4.png | simple | <table><tr><td>Variable</td><td><i>r</i></td><td>P-value</td></tr><tr><td>Age, years</td><td>0.023</td><td>0.400</td></tr><tr><td>Gender</td><td>0.031</td><td>0.359</td></tr><tr><td>Course of disease, years</td><td>0.267</td><td>0.002</td></tr><tr><td>SBP, mmHg</td><td>0.429</td><td><0.001</td></tr><tr><td>DBP, mmHg... | <table><tr><td>Variable</td><td>r</td><td>P-value</td></tr></table> | <table><tr><td>Age, years</td><td>0.023</td><td>0.400</td></tr><tr><td>Gender</td><td>0.031</td><td>0.359</td></tr><tr><td>Course of disease, years</td><td>0.267</td><td>0.002</td></tr><tr><td>SBP, mmHg</td><td>0.429</td><td><0.001</td></tr><tr><td>DBP, mmHg</td><td>0.438</td><td><0.001</td></tr><tr><td>BMI, kg/m2</td>... |
6064f08e5ece8d39f4e8fed3eefaccdc118b548a55ec13ac952cabbcd2c9e078.png | simple | <table><tr><td>Concomitant conditions</td><td>Number</td><td>Percent</td></tr><tr><td>Heart disease</td><td>37</td><td>33.9</td></tr><tr><td>Current smokers</td><td>36</td><td>33.0</td></tr><tr><td>Diabetes mellitus</td><td>26</td><td>23.9</td></tr><tr><td>Osteoarthritis</td><td>24</td><td>22.0</td></tr><tr><td>Previou... | <table><tr><td>Concomitant conditions</td><td>Number</td></tr><tr><td>Heart disease</td><td>37</td></tr><tr><td>Current smokers</td><td>36</td></tr><tr><td>Diabetes mellitus</td><td>26</td></tr><tr><td>Osteoarthritis</td><td>24</td></tr><tr><td>Previous cancer</td><td>22</td></tr><tr><td>Peripheral arterial disease</td... | <table><tr><td>Percent</td></tr><tr><td>33.9</td></tr><tr><td>33.0</td></tr><tr><td>23.9</td></tr><tr><td>22.0</td></tr><tr><td>20.2</td></tr><tr><td>17.4</td></tr><tr><td>13.8</td></tr><tr><td>13.8</td></tr><tr><td>11.9</td></tr><tr><td>11.0</td></tr><tr><td>9.2</td></tr><tr><td>9.2</td></tr><tr><td>8.2</td></tr><tr><... |
5ecd26dcc204108f35cdf0bc336a447479b9c3400760d3fb3308bf25a7081d36.png | simple | <table><tr><td> </td><td>Total specimen length (cm)</td></tr><tr><td>Cook</td><td>4.73</td></tr><tr><td>Boston Scientific</td><td>2.98</td></tr><tr><td>Olympus</td><td>4.26</td></tr><tr><td>Covidien</td><td>5.07</td></tr><tr><td>Trucut</td><td>1.55</td></tr></table> | <table><tr><td></td><td>Total specimen length (cm)</td></tr><tr><td>Cook</td><td>4.73</td></tr><tr><td>Boston Scientific</td><td>2.98</td></tr><tr><td>Olympus</td><td>4.26</td></tr></table> | <table><tr><td></td><td>Total specimen length (cm)</td></tr><tr><td>Covidien</td><td>5.07</td></tr><tr><td>Trucut</td><td>1.55</td></tr></table> |
3865ddc10901ce7361589116ca3264438bbe0b5006867ad894bebd25d76b8574.png | complex | <table><tr><td> </td><td colspan="4">Boys</td><td colspan="4">Girls</td><td rowspan="3"><i>P</i>-value</td></tr><tr><td> </td><td><i>n</i></td><td>HBP</td><td>HNBP</td><td>HT</td><td><i>n</i></td><td>HBP</td><td>HNBP</td><td>HT</td></tr><tr><td colspan="10">Fourth graders (age 9–10 years)</td></tr><tr><td> SBP</t... | <table><tr><td></td><td colspan="4">Boys</td><td>Girls</td></tr><tr><td></td><td>n</td><td>HBP</td><td>HNBP</td><td>HT</td><td>n</td></tr><tr><td colspan="6"></td></tr><tr><td colspan="6">Fourth graders (age 9–10 years)</td></tr><tr><td>SBP</td><td>661</td><td>53 (8.0)</td><td>51 (7.7)</td><td>2 (0.3)</td><td>636</td><... | <table><tr><td colspan="3">Girls</td><td rowspan="3">P-value</td></tr><tr><td>HBP</td><td>HNBP</td><td>HT</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="4">Fourth graders (age 9–10 years)</td></tr><tr><td>46 (7.2)</td><td>42 (6.6)</td><td>4 (0.6)</td><td>0.603</td></tr><tr><td>73 (11.5)</td><td>61 (9.6)</td><t... |
c6022497e6fc4d084172f5391d3ef55815f7769306beaa580d6c1210e09eb890.png | simple | <table><tr><td>Round</td><td>Positive Selection (+)</td><td>PCR Cycles</td><td>Negative Selection (–)</td><td>PCR Cycles</td></tr><tr><td>1</td><td>Immobilized Target (IT) 24 h</td><td>9</td><td>–</td><td>–</td></tr><tr><td>2</td><td>IT 18 h</td><td>15</td><td>BSA Immobilized Negative Target (INT) 22 ... | <table><tr><td>Round</td><td>Positive Selection (+)</td><td>PCR Cycles</td><td>Negative Selection (–)</td><td>PCR Cycles</td></tr><tr><td>1</td><td>Immobilized Target (IT) 24 h</td><td>9</td><td>–</td><td>–</td></tr><tr><td>2</td><td>IT 18 h</td><td>15</td><td>BSA Immobilized Negative Target (INT) 22 h</td><td>16</td><... | <table><tr><td>Round</td><td>Positive Selection (+)</td><td>PCR Cycles</td><td>Negative Selection (–)</td><td>PCR Cycles</td></tr><tr><td>11</td><td>IT 5 s, Competitive Elution with 2.5 μg/mL free alpha toxin, 5 s</td><td>19</td><td>IT 5 s, Competitive Elution with 20 μg/mL free BSA, 24 h</td><td>7</td></tr><tr><td>12<... |
9302dbc8f6ffc1a3f10b1f7a3bf8a3cf5a0202bf7275ac1b20bdc0407ca03eb7.png | simple | <table><tr><td>No. <sup>a</sup></td><td>Protein name <sup>b</sup></td><td>C<sub>d</sub><sup>c</sup></td><td>No.</td><td>Protein name</td><td>C<sub>b</sub><sup>d</sup></td><td>No.</td><td>Protein name</td><td>C<sub>c</sub><sup>e</sup></td></tr><tr><td>175</td><td>EGFR</td><td>0.411</td><td>166</td><td>PGH2</td><td>0.177... | <table><tr><td>No. a</td><td>Protein name b</td><td>Cdc</td><td>No.</td><td>Protein name</td><td>Cbd</td><td>No.</td><td>Protein name</td></tr><tr><td>175</td><td>EGFR</td><td>0.411</td><td>166</td><td>PGH2</td><td>0.177</td><td>207</td><td>KPCA</td></tr><tr><td>149</td><td>ADRB1</td><td>0.404</td><td>234</td><td>PP2BA... | <table><tr><td>Cce</td></tr><tr><td>0.500</td></tr><tr><td>0.496</td></tr><tr><td>0.496</td></tr><tr><td>0.496</td></tr><tr><td>0.447</td></tr><tr><td>0.445</td></tr><tr><td>0.445</td></tr><tr><td>0.445</td></tr><tr><td>0.445</td></tr><tr><td>0.445</td></tr></table> |
eb5e7216e4a6aeb9d7691582da5585b1657a034321f8d4a750e7c72debb34c23.png | complex | <table><tr><td></td><td colspan="3">E-learning group</td><td colspan="3">Non-e-learning group</td><td></td></tr><tr><td>n</td><td>Mean rate</td><td>SD</td><td>n</td><td>Mean rate</td><td>SD</td><td></td></tr><tr><td>Overall</td><td>151</td><td>1·24</td><td>0·26</td><td>144</td><td>1·00</td><td>0·16<... | <table><tr><td></td><td colspan="3">E-learning group</td><td colspan="3">Non-e-learning group</td><td></td></tr><tr><td>n</td><td>Mean rate</td><td>SD</td><td>n</td><td>Mean rate</td><td>SD</td><td></td><td></td></tr></table> | <table><tr><td>Overall</td><td>151</td><td>1·24</td><td>0·26</td><td>144</td><td>1·00</td><td>0·16</td><td>a</td></tr><tr><td>Lower score group</td><td>86</td><td>1·34</td><td>0·29</td><td>80</td><td>1·03</td><td>0·18</td><td>a</td></tr><tr><td>Higher score group</td><td>65</td><td>1·19</td><td>0·14</td><td>64</td><td>... |
3b97b77b764db39997b88887f069fd7d36ef3c617e201838834fe5f9707e4c1c.png | simple | <table><tr><td>Patient</td><td>Age</td><td>EGA</td><td>Parity</td><td>PMH/comorbidities</td><td>Symptoms</td><td>Outcome</td></tr><tr><td>1</td><td>37</td><td>13</td><td>G6P2122</td><td>None</td><td>Urinary retention, bilateral costo-vertebral tenderness and thick white discharge on speculum exam</td><td>Self-catheteri... | <table><tr><td>Patient</td><td>Age</td><td>EGA</td><td>Parity</td><td>PMH/comorbidities</td><td>Symptoms</td><td>Outcome</td></tr><tr><td>1</td><td>37</td><td>13</td><td>G6P2122</td><td>None</td><td>Urinary retention, bilateral costo-vertebral tenderness and thick white discharge on speculum exam</td><td>Self-catheteri... | <table><tr><td>Patient</td><td>Age</td><td>EGA</td><td>Parity</td><td>PMH/comorbidities</td><td>Symptoms</td><td>Outcome</td></tr><tr><td>2</td><td>42</td><td>13</td><td>G5P3013</td><td>Infertility, LEEP, salpingectomy</td><td>Urinary retention</td><td>Self-catheterization, pessary placement</td></tr><tr><td>3</td><td>... |
9a84fecd4ce98ec49d6c502fac4fa9376d6e6535eff5a3283b1719442223fdc9.png | simple | <table><tr><td>Dimension of Governance</td><td>What it captures -</td></tr><tr><td>Control of corruption</td><td>Perceptions of the extent to which public power is exercised for private gain, including both petty and grand forms of corruption, as well as “capture” of the state by elites and private interest... | <table><tr><td>Dimension of Governance</td><td>What it captures -</td></tr><tr><td>Control of corruption</td><td>Perceptions of the extent to which public power is exercised for private gain, including both petty and grand forms of corruption, as well as “capture” of the state by elites and private interests</td></tr><... | <table><tr><td>Political stability</td><td>Perceptions of the likelihood that the government will be destabilized or overthrown by unconstitutional or violent means, including politically-motivated violence and terrorism</td></tr><tr><td>Regulatory quality</td><td>Perceptions of the ability of the government to formula... |
c3c48bcd85a1a5177a3ef741f3cea6339ae416adc3b6de0a72b1448f45f1f476.png | complex | <table><tr><td rowspan="2">AgeLesion</td><td colspan="2">≤ 20</td><td colspan="2">20 < age ≤ 40</td><td colspan="2">> 40</td><td rowspan="2">Fisher’sExact Test</td></tr><tr><td>Frequency</td><td>Percentage</td><td>Frequency</td><td>Percentage</td><td>Frequency</td><td>Percentage</td></tr><tr><td... | <table><tr><td>AgeLesion</td><td colspan="2">≤ 20</td><td colspan="2">20 < age ≤ 40</td><td colspan="2">> 40</td><td>Fisher’sExact Test</td></tr></table> | <table><tr><td>AgeLesion</td><td>Frequency</td><td>Percentage</td><td>Frequency</td><td>Percentage</td><td>Frequency</td><td>Percentage</td><td>Fisher’sExact Test</td></tr><tr><td>Odontogenic cysts</td><td>10</td><td>16.9</td><td>36</td><td>61.0</td><td>13</td><td>22.0</td><td rowspan="4">20.62 df=4 p< 0.0001</td></tr>... |
a52c0f276b273a14ad1a6b8424887106601733310cc62e7d326ad01ecfac1bd2.png | simple | <table><tr><td>Studies</td><td>Outcomes reported</td><td>Types of participants</td></tr><tr><td>Cavallasca 2008 [16]</td><td>Stillbirth, prematurity, low for gestational age</td><td>SLE versus SAPS in pregnancy</td></tr><tr><td>Huong 2006 [12]</td><td>Fetal death, pre-eclampsia, arterial occlusion, arterial and venous ... | <table><tr><td>Studies</td></tr><tr><td>Cavallasca 2008 [16]</td></tr><tr><td>Huong 2006 [12]</td></tr><tr><td>Ideguchi 2013 [17]</td></tr><tr><td>Luo 2015 [18]</td></tr><tr><td>Mecacci 2009 [19]</td></tr><tr><td>Paramo 2002 [11]</td></tr><tr><td>Muñoz Rodriguez 2000 [13]</td></tr><tr><td>Tarr 2007 [14]</td></tr><tr><... | <table><tr><td>Outcomes reported</td><td>Types of participants</td></tr><tr><td>Stillbirth, prematurity, low for gestational age</td><td>SLE versus SAPS in pregnancy</td></tr><tr><td>Fetal death, pre-eclampsia, arterial occlusion, arterial and venous thrombosis, premature</td><td>SLE versus SAPS in pregnancy</td></tr><... |
b346f7725803f9cd8a9a3ab5fac49dbf2448a9e6d1dbdcbfdf90bd775265750b.png | simple | <table><tr><td><i>Patients/City and State of origin</i></td><td><i>Sex</i></td><td><i>Age</i></td><td><i>rN-Bac</i><i>OD</i></td><td><i>rN-E. coli</i><i>OD</i></td><td><i>Results<sup>1</sup></i></td><td><i>Patients/City and State of origin</i></td><td><i>Sex</i></td><td><i>Age</i></td><td><i>rN-Bac</i><i>OD</i></td><td... | <table><tr><td>Patients/City and State of origin</td><td>Sex</td><td>Age</td><td>rN-BacOD</td><td>rN-E. coliOD</td><td>Results1</td><td>Patients/City and State of origin</td><td>Sex</td><td>Age</td><td>rN-BacOD</td><td>rN-E. coliOD</td><td>Results1</td></tr><tr><td>1-Par-SC</td><td>M</td><td>20</td><td>0.109</td><td>0.... | <table><tr><td>Patients/City and State of origin</td><td>Sex</td><td>Age</td><td>rN-BacOD</td><td>rN-E. coliOD</td><td>Results1</td><td>Patients/City and State of origin</td><td>Sex</td><td>Age</td><td>rN-BacOD</td><td>rN-E. coliOD</td><td>Results1</td></tr><tr><td>4-Bel-SC</td><td>F</td><td>50</td><td>1.058</td><td>0.... |
4e0ff349ed991d81a161e7a0ce16bb7c72ba5139a4cf1b3dd999a84707008a9a.png | simple | <table><tr><td>Symptoms of respiratory disease</td><td>YES</td><td>NO</td><td>% Positive answers</td></tr><tr><td>Do you cough frequently? (796 answers)</td><td>173</td><td>623</td><td>27.8</td></tr><tr><td>Do you frequently have sputum production with cough? (802 a.)</td><td>281</td><td>521</td><td>53.9</td></tr><tr><... | <table><tr><td>Symptoms of respiratory disease</td><td>YES</td><td>NO</td><td>% Positive answers</td></tr><tr><td>Do you cough frequently? (796 answers)</td><td>173</td><td>623</td><td>27.8</td></tr><tr><td>Do you frequently have sputum production with cough? (802 a.)</td><td>281</td><td>521</td><td>53.9</td></tr><tr><... | <table><tr><td>Symptoms of respiratory disease</td><td>YES</td><td>NO</td><td>% Positive answers</td></tr><tr><td>Do you perceive wheezing in your chest when you breathe at night? (599 a.)</td><td>69</td><td>530</td><td>13</td></tr><tr><td>Do you frequently catch a cold lasting more than that of other people you know? ... |
99c3efc732447909c73e05f621888f4314067a3e33a47286224d2367e67bd96b.png | simple | <table><tr><td>Class</td><td>Species</td><td>T (°C)</td><td>ERK</td><td>%AT-rich</td><td>%GC-rich</td></tr><tr><td>Mammalia</td><td>Mus musculus</td><td>36.9</td><td>-16.32</td><td>23.22</td><td>24.56</td></tr><tr><td>Mammalia</td><td>Rattus norvegicus</td><td>37.3</td><td>-16.27</td><td>22.82</td><td>24.91</td></... | <table><tr><td>Class</td><td>Species</td><td>T (°C)</td><td>ERK</td><td>%AT-rich</td><td>%GC-rich</td></tr><tr><td>Mammalia</td><td>Mus musculus</td><td>36.9</td><td>-16.32</td><td>23.22</td><td>24.56</td></tr><tr><td>Mammalia</td><td>Rattus norvegicus</td><td>37.3</td><td>-16.27</td><td>22.82</td><td>24.91</td></tr><t... | <table><tr><td>Class</td><td>Species</td><td>T (°C)</td><td>ERK</td><td>%AT-rich</td><td>%GC-rich</td></tr><tr><td>Mammalia</td><td>Bos taurus</td><td>38</td><td>-15.97</td><td>23.14</td><td>25.00</td></tr><tr><td>Birds</td><td>Gallus gallus</td><td>39</td><td>-16.01</td><td>23.59</td><td>24.83</td></tr><tr><td>Reptili... |
bc6dbee4451fe698d344f99c420bb1034ce8bcf2165b0cca51164a3d895f57cf.png | simple | <table><tr><td></td><td>Initial population iTFA intakes,<sup>2</sup> E%</td></tr><tr><td>Base case</td><td>0.3<sup>3</sup></td></tr><tr><td>Scenario 1</td><td>0.15</td></tr><tr><td>Scenario 2</td><td>0.45</td></tr><tr><td>Scenario 3</td><td>0.7</td></tr></table> | <table><tr><td></td><td>Initial population iTFA intakes,2 E%</td></tr></table> | <table><tr><td>Base case</td><td>0.33</td></tr><tr><td>Scenario 1</td><td>0.15</td></tr><tr><td>Scenario 2</td><td>0.45</td></tr><tr><td>Scenario 3</td><td>0.7</td></tr></table> |
6634274af53bdf7c362be4a3d0e32a4340021d03ebdceb3c1201fe9e099165b0.png | simple | <table><tr><td>Trait</td><td>Variantidentifier</td><td>Chr</td><td>Position</td><td>ea/nea</td><td>Eaf</td><td>Beta</td><td>s.e.</td><td><i>P</i>-value</td><td>Q<i>P</i>-value</td><td><i>N</i>samples</td><td>Candidategene</td><td>eQTL</td><td>Function</td></tr><tr><td>Glycine</td><td>chr3:125905336:D</td><td>3</td><td>... | <table><tr><td>Trait</td><td>Variantidentifier</td><td>Chr</td><td>Position</td><td>ea/nea</td><td>Eaf</td><td>Beta</td><td>s.e.</td><td>P-value</td><td>QP-value</td><td>Nsamples</td><td>Candidategene</td><td>eQTL</td><td>Function</td></tr><tr><td>Glycine</td><td>chr3:125905336:D</td><td>3</td><td>125905336</td><td>A/A... | <table><tr><td>Trait</td><td>Variantidentifier</td><td>Chr</td><td>Position</td><td>ea/nea</td><td>Eaf</td><td>Beta</td><td>s.e.</td><td>P-value</td><td>QP-value</td><td>Nsamples</td><td>Candidategene</td><td>eQTL</td><td>Function</td></tr><tr><td>cine</td><td>40</td><td></td><td>5877295</td><td></td><td>5</td><td></td... |
33f1377865c2b02958a4c4e4364cd61327a2f05a27a01b3c1f10afbb44597cb8.png | simple | <table><tr><td>Supplement Name</td><td>Male, <i>n</i> = 152, <i>n</i> (%)</td><td>Female, <i>n</i> = 224, <i>n</i> (%)</td><td><i>p</i> value</td></tr><tr><td>B Vitamin Complex</td><td>10 (6.6) <sup>b</sup></td><td>32 (14.3) <sup>a</sup></td><td>0.020</td></tr><tr><td>Calcium</td><td>14 (9.2) <sup>b</sup></td><td>83 (3... | <table><tr><td>Supplement Name</td><td>Male, n = 152, n (%)</td><td>Female, n = 224, n (%)</td><td>p value</td></tr><tr><td>B Vitamin Complex</td><td>10 (6.6) b</td><td>32 (14.3) a</td><td>0.020</td></tr><tr><td>Calcium</td><td>14 (9.2) b</td><td>83 (37.1) a</td><td><0.001</td></tr><tr><td>Fish Oil</td><td>10 (6.6) b</... | <table><tr><td>Magnesium</td><td>6 (3.9) b</td><td>31 (13.8) a</td><td>0.001</td></tr><tr><td>Omega 3,6,9</td><td>13 (8.6) b</td><td>36 (16.1) a</td><td>0.042</td></tr><tr><td>Vitamin D</td><td>33 (21.7) b</td><td>84 (37.5) a</td><td>0.001</td></tr></table> |
864e55b0b5d2117756a69bb95cff7e7b6cbee4f29c1bd7481c35238f202dd39d.png | complex | <table><tr><td colspan="9">Dietary Fiber (g/day)</td></tr><tr><td>Age (y)</td><td><i>n</i></td><td>2001–2010</td><td>2001–2002</td><td>2003–2004</td><td>2005–2006</td><td>2007–2008</td><td>2009–2010</td><td><i>p</i>-value for trend</td></tr><tr><td>4–18</td><td>14,973</td><td>1... | <table><tr><td>Dietary Fiber (g/day)</td></tr><tr><td>Age (y)</td></tr><tr><td>4–18</td></tr><tr><td>19–50</td></tr><tr><td>51+</td></tr></table> | <table><tr><td colspan="8">Dietary Fiber (g/day)</td></tr><tr><td>n</td><td>2001–2010</td><td>2001–2002</td><td>2003–2004</td><td>2005–2006</td><td>2007–2008</td><td>2009–2010</td><td>p-value for trend</td></tr><tr><td>14,973</td><td>13.2 ± 0.1</td><td>12.8 ± 0.2</td><td>13.2 ± 0.3</td><td>13.2 ± 0.3</td><td>13.0 ± 0.4... |
7a94c72e4074a373c33cd74bfee65d5d3ebaf7412f149ad2d73394dc8bf3a649.png | simple | <table><tr><td>Aim</td><td>Instrument</td><td>Applied to</td><td>t<sub>0</sub></td><td>t<sub>6</sub></td><td>t<sub>12</sub></td><td>t<sub>24</sub></td><td>t<sub>h</sub></td></tr><tr><td>Anamnestic data</td><td>Baseline CRF</td><td>GP</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Quality of life of pati... | <table><tr><td>Aim</td><td>Instrument</td><td>Applied to</td><td>t0</td><td>t6</td><td>t12</td><td>t24</td><td>th</td></tr><tr><td>Anamnestic data</td><td>Baseline CRF</td><td>GP</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Quality of life of patient</td><td>EQ-5D</td><td>Patient, informal caregiver a... | <table><tr><td> status of the patient</td><td>CGI</td><td>GP</td><td>X</td><td>X</td><td>X</td><td>X</td><td></td></tr><tr><td>Behavioural problems patient</td><td>NOSGER (Subtest)</td><td>Informal caregiver</td><td>X</td><td></td><td>X</td><td>X</td><td></td></tr><tr><td>ADL patient</td><td>Barthel-Index</td><td>Infor... |
ab7685e94cf5d9cd2d0f1e63342323f327f757c6fa286d2b644068831730dbeb.png | complex | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code</td></tr><tr><td rowspan="8"> </td><td rowspan="8">Current classification</td><td>Domain <i>Bacteria</i></td><td>TAS [19]</td></tr><tr><td>Phylum <i>Proteobacteria</i></td><td>TAS [20]</td></tr><tr><td>Class <i>Alphaproteobacteria</i></td><td>TA... | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code</td></tr><tr><td rowspan="8"></td><td rowspan="8">Current classification</td><td>Domain Bacteria</td><td>TAS [19]</td></tr><tr><td>Phylum Proteobacteria</td><td>TAS [20]</td></tr><tr><td>Class Alphaproteobacteria</td><td>TAS [21]</td></tr><tr><t... | <table><tr><td></td><td>gy source</td><td>anotroph</td><td>25]</td></tr><tr><td>MIGS-6</td><td>Habitat</td><td>Soil, root nodule, host</td><td>TAS [3]</td></tr><tr><td>MIGS-15</td><td>Biotic relationship</td><td>Free living, Symbiotic</td><td>TAS [3]</td></tr><tr><td>MIGS-14</td><td>Pathogenicity</td><td>None</td><td>N... |
b4064554ce1c0e952866d4b0072c51dd8ca3ce2c700107b1dcca3b671d9aefd8.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="2">Protein source</td><td colspan="2">Protein level</td><td rowspan="2">SEM</td><td colspan="3"><i>P</i></td></tr><tr><td>Cottonseed meal</td><td>Soybean meal</td><td>12 %</td><td>14 %</td><td>Source</td><td>Level</td><td>Source × Level</td></tr><tr><td>Initial body... | <table><tr><td rowspan="2">Item</td><td colspan="2">Protein source</td><td colspan="2">Protein level</td><td rowspan="2">SEM</td><td colspan="3">P</td></tr><tr><td>Cottonseed meal</td><td>Soybean meal</td><td>12 %</td><td>14 %</td><td>Source</td><td>Level</td><td>Source × Level</td></tr><tr><td>Initial body weight, kg<... | <table><tr><td>Daily N intake, g/d</td><td>64.63</td><td>61.18</td><td>58.28</td><td>67.54</td><td>1.15</td><td>0.04</td><td><0.01</td><td>0.91</td></tr><tr><td>Daily N deposition, g/d</td><td>20.43</td><td>20.87</td><td>20.53</td><td>20.76</td><td>0.22</td><td>0.17</td><td>0.47</td><td>0.91</td></tr><tr><td>Daily N ex... |
ebe294426e85ba237ea86019b35b28f70f232f3f772a2146d734a1f0c1e7eb12.png | simple | <table><tr><td>Study</td><td>Number of patients</td><td>Morbidity</td><td>Mortality</td></tr><tr><td>Yamaguchi et al.</td><td>107</td><td>-</td><td>5.8%</td></tr><tr><td>Talamini et al. </td><td>106</td><td>47%</td><td>3.8%</td></tr><tr><td>Beger et al.</td><td>98</td><td>-</td><td>3.2%</td></tr><tr><td>Nagakawa et al.... | <table><tr><td>Study</td><td>Number of patients</td><td>Morbidity</td><td>Mortality</td></tr></table> | <table><tr><td>Yamaguchi et al.</td><td>107</td><td>-</td><td>5.8%</td></tr><tr><td>Talamini et al.</td><td>106</td><td>47%</td><td>3.8%</td></tr><tr><td>Beger et al.</td><td>98</td><td>-</td><td>3.2%</td></tr><tr><td>Nagakawa et al.</td><td>1423</td><td>-</td><td>1.3%</td></tr><tr><td>Di Giorgio et al.</td><td>94</td>... |
fb3e4f0226969bf7ae6a9464b546416c93c83e28d39186560202a62ada4aa550.png | simple | <table><tr><td>Group</td><td>Cases </td><td>Osteomyelitis healed (%)</td><td>Bone union</td></tr><tr><td>IRI and soft tissue defects </td><td>152</td><td>131 (86.2%)</td><td>147 (96.7%)</td></tr><tr><td>Simple IRI</td><td>65</td><td>57 (87.7%)</td><td>64 (98.5%)</td></tr><tr><td>Total </td><td>217</td><td>188 (86.6%)</... | <table><tr><td>Group</td><td>Cases</td><td>Osteomyelitis healed (%)</td><td>Bone union</td></tr><tr><td>IRI and soft tissue defects</td><td>152</td><td>131 (86.2%)</td><td>147 (96.7%)</td></tr><tr><td>S</td><td>65</td><td>5</td><td></td></tr></table> | <table><tr><td>imple IRI</td><td></td><td>7 (87.7%)</td><td>64 (98.5%)</td></tr><tr><td>Total</td><td>217</td><td>188 (86.6%)</td><td>211 (97.2%)</td></tr></table> |
e11a856cda833c0917eaa97e148fdb7c6e9c5c98da471eac29bcbeab5d10920a.png | simple | <table><tr><td>Selenoprotein gene</td><td>Brief information in the NCBI database.</td></tr><tr><td><i>SPS</i></td><td>XM_002129490 PREDICTED: similar to selenophosphate synthetase 1 (LOC100182599)</td></tr><tr><td><i>SelH</i></td><td>XM_002124882 PREDICTED: similar to Selenoprotein H (SelH) (LOC100184326)</td></tr><tr>... | <table><tr><td>Selenoprotein gene</td><td>Brief information in the NCBI database.</td></tr></table> | <table><tr><td>SPS</td><td>XM_002129490 PREDICTED: similar to selenophosphate synthetase 1 (LOC100182599)</td></tr><tr><td>SelH</td><td>XM_002124882 PREDICTED: similar to Selenoprotein H (SelH) (LOC100184326)</td></tr><tr><td>SelO</td><td>XM_002124815 PREDICTED: similar to predicted protein (LOC100179326)</td></tr><tr>... |
9e8b365511d256e4b787bf66a9e4005acd937741f06770355212680b19fc9d2b.png | simple | <table><tr><td><i>Predictor</i></td><td><i>β</i></td><td><i>t</i></td><td><i>p</i></td></tr><tr><td>Distance</td><td>3.810</td><td>2.575</td><td>0.012</td></tr><tr><td>Time of day</td><td>−0.067</td><td>−0.622</td><td>0.536</td></tr><tr><td>SUL</td><td>0.119</td><td>1.101</td><td>0.274</td></tr></table... | <table><tr><td>Predictor</td><td>β</td></tr><tr><td>Distance</td><td>3.810</td></tr><tr><td>Time of day</td><td>−0.067</td></tr><tr><td>SUL</td><td>0.119</td></tr></table> | <table><tr><td>t</td><td>p</td></tr><tr><td>2.575</td><td>0.012</td></tr><tr><td>−0.622</td><td>0.536</td></tr><tr><td>1.101</td><td>0.274</td></tr></table> |
f90cf2996f7f9b3c83f8b6209070a5d37585dacb4aee8ce8bae43b1026d0d93f.png | simple | <table><tr><td>Culture #</td><td>Culture duration (days)</td><td>Final culture density per ml ( × 10<sup>8</sup>)</td><td>No. of generations in the culture (<i>n</i>)</td><td>Total no. of generations (cumul)</td><td>GEN.</td><td>First evolved mutant isolated</td><td>Second evolved mutant isolated</td></tr><tr><td>... | <table><tr><td>Culture #</td><td>Culture duration (days)</td><td>Final culture density per ml ( × 108)</td><td>No. of generations in the culture (n)</td><td>Total no. of generations (cumul)</td><td>GEN.</td><td>First evolved mutant isolated</td><td>Second evolved mutant isolated</td></tr><tr><td>1</td><td>3</td><td>1.2... | <table><tr><td>Culture #</td><td>Culture duration (days)</td><td>Final culture density per ml ( × 108)</td><td>No. of generations in the culture (n)</td><td>Total no. of generations (cumul)</td><td>GEN.</td><td>First evolved mutant isolated</td><td>Second evolved mutant isolated</td></tr><tr><td>14</td><td>2</td><td>1.... |
ad29e18a07f26741e50a663d2f8879104eea9861bd526805acbda86b797af0c2.png | complex | <table><tr><td rowspan="2">Country</td><td rowspan="2">Antimicrobial class</td><td colspan="2">Correlation coefficient</td></tr><tr><td>Cattle</td><td>Pigs</td></tr><tr><td>Denmark</td><td>Aminoglycosides</td><td>−0.91</td><td>−0.61</td></tr><tr><td>Switzerland</td><td>Aminoglycosides</td><td>−0.94</t... | <table><tr><td rowspan="2">Country</td><td rowspan="2">Antimicrobial class</td><td colspan="2">Correlation coefficient</td></tr><tr><td>Cattle</td><td>Pigs</td></tr><tr><td>Denmark</td><td>Aminoglycosides</td><td>−0.91</td><td>−0.61</td></tr><tr><td>Switzerland</td><td>Aminoglycosides</td><td>−0.94</td><td>−0.90</td></... | <table><tr><td rowspan="2">Country</td><td rowspan="2">Antimicrobial class</td><td colspan="2">Correlation coefficient</td></tr><tr><td>Cattle</td><td>Pigs</td></tr><tr><td>Denmark</td><td>Others</td><td>0.94</td><td>−0.27</td></tr><tr><td>Switzerland</td><td>Others</td><td>NA</td><td>−0.66</td></tr><tr><td>Denmark</td... |
f18f682db8cfd5cf99a04b6c038d4172f57bb3a2dbcdb6d2cd951d0f50cab297.png | simple | <table><tr><td>Number</td><td>Case number</td><td>Exon</td><td>Nucleotide change</td><td>Amino acid</td></tr><tr><td>1</td><td>36T</td><td>19</td><td>c.2199A>G</td><td>p.P733P</td></tr><tr><td>2</td><td>41T</td><td>19</td><td>c.2202A>G</td><td>p.E734E</td></tr><tr><td>3</td><td>10T</td><td>19</td><td>c.2250A>G... | <table><tr><td>Number</td><td>Case number</td><td>Exon</td><td>Nucleotide change</td><td>Amino acid</td></tr><tr><td>1</td><td>36T</td><td>19</td><td>c.2199A>G</td><td>p.P733P</td></tr><tr><td>2</td><td>41T</td><td>19</td><td>c.2202A>G</td><td>p.E734E</td></tr></table> | <table><tr><td>3</td><td>10T</td><td>19</td><td>c.2250A>G</td><td>p.A750A</td></tr><tr><td>4</td><td>56T</td><td>19</td><td>c.2262A>G</td><td>p.K754K</td></tr><tr><td>5</td><td>26T, 48T</td><td>20</td><td>c.2286A>G</td><td>p.E762E</td></tr><tr><td>6</td><td>32T</td><td>21</td><td>c.2523G>A</td><td>p.R841R</td></tr><tr>... |
967e6b140482ec1ba18e91b34139a1c7c18b1dc5e3154a86af1aa061257c1a7e.png | complex | <table><tr><td>Molecular variation</td><td>df</td><td>SS</td><td>MS</td><td>%</td><td>Φ<sub>PT</sub></td></tr><tr><td colspan="6">All 20 populations grouped in two regions</td></tr><tr><td> Among regions</td><td>1</td><td>1108.988</td><td>1108.988</td><td>14</td><td>0.42</td></tr><tr><td> Among populations within ... | <table><tr><td>Molecular variation</td><td>df</td><td>SS</td></tr><tr><td colspan="3">All 20 populations grouped in two regions</td></tr><tr><td>Among regions</td><td>1</td><td>1108.988</td></tr><tr><td>Among populations within regions</td><td>18</td><td>3639.084</td></tr><tr><td>Within populations</td><td>277</td><td>... | <table><tr><td>MS</td><td>%</td><td>ΦPT</td></tr><tr><td colspan="3">All 20 populations grouped in two regions</td></tr><tr><td>1108.988</td><td>14</td><td>0.42</td></tr><tr><td>202.171</td><td>28</td><td></td></tr><tr><td>24.288</td><td>57</td><td></td></tr><tr><td colspan="3">All 20 populations together</td></tr><tr>... |
13b711d33cccae5ea46d43ffb3f5ef660209b54cf87afe21ab5c38483b5cd5d1.png | complex | <table><tr><td></td><td colspan="6">Year</td></tr><tr><td></td><td>2000</td><td>2001</td><td>2002</td><td>2003</td><td>2004</td><td>2005</td></tr><tr><td>Total</td><td>24.6</td><td>26.1</td><td>27.3</td><td>27.5</td><td>28.2</td><td>28.0</td></tr><tr><td>Mother's Education</td><td></td><td></td><td></td><td></td><td></... | <table><tr><td></td><td colspan="2">Year</td></tr><tr><td></td><td>2000</td><td>2001</td></tr><tr><td>Total</td><td>24.6</td><td>26.1</td></tr><tr><td>Mother's Education</td><td></td><td></td></tr><tr><td>No school</td><td>28.9</td><td>30.7</td></tr><tr><td>Primary school</td><td>25.8</td><td>27.7</td></tr><tr><td>Juni... | <table><tr><td colspan="4">Year</td></tr><tr><td>2002</td><td>2003</td><td>2004</td><td>2005</td></tr><tr><td>27.3</td><td>27.5</td><td>28.2</td><td>28.0</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>32.3</td><td>33.7</td><td>32.7</td><td>33.4</td></tr><tr><td>28.8</td><td>29.9</td><td>31.1</td><td>30.0... |
6e45850b32d79ee9b149ba441332bc63c1f1e28163942407f9cc0558f9d7eb9f.png | simple | <table><tr><td></td><td>Group A(min)</td><td>Group B(min)</td><td>Group C(min)</td><td>Group D(min)</td><td>Group E(min)</td><td>Group F(min)</td><td>Group G(min)</td><td>Group H(min)</td><td>Group I(min)</td></tr><tr><td>U87</td><td>64</td><td>0.29</td><td>0.57</td><td>27</td><td>54</td><td>27</td><td>54</td><td>32</t... | <table><tr><td></td><td>Group A(min)</td><td>Group B(min)</td><td>Group C(min)</td><td>Group D(min)</td><td>Group E(min)</td><td>Group F(min)</td><td>Group G(min)</td><td>Group H(min)</td><td>Group I(min)</td></tr><tr><td>U87</td><td>64</td><td>0.29</td><td>0.57</td><td>27</td><td>54</td><td>27</td><td>54</td><td>32</t... | <table><tr><td>U251</td><td>64</td><td>0.29</td><td>0.57</td><td>25</td><td>50</td><td>25</td><td>50</td><td>32</td><td>64</td></tr><tr><td>SHG44</td><td>64</td><td>0.29</td><td>0.57</td><td>28</td><td>56</td><td>28</td><td>56</td><td>32</td><td>64</td></tr></table> |
5197997774cc6b73868478ac8d55497e8f27d9e75550bc917b015534536837d8.png | complex | <table><tr><td></td><td></td><td colspan="2">JA ALGO</td><td colspan="4">ParBiConstruct</td></tr><tr><td>P</td><td>k</td><td>RES.MEM(Mb)</td><td>SHR.MEM(Mb)</td><td>RES.MEM(Mb)</td><td>efficiency</td><td>SHR.MEM(Mb)</td><td>efficiency</td></tr><tr><td>8</td><td>21</td><td>903.714</td><td>3.690</td><td>244.603</td><td>3... | <table><tr><td></td><td></td><td colspan="2">JA ALGO</td><td colspan="4">ParBiConstruct</td></tr><tr><td>P</td><td>k</td><td>RES.MEM(Mb)</td><td>SHR.MEM(Mb)</td><td>RES.MEM(Mb)</td><td>efficiency</td><td>SHR.MEM(Mb)</td><td>efficiency</td></tr><tr><td>8</td><td>21</td><td>903.714</td><td>3.690</td><td>244.603</td><td>3... | <table><tr><td>24</td><td>27</td><td>214.681</td><td>16.271</td><td>61.674</td><td>3.481</td><td>6.690</td><td>2.432</td></tr><tr><td>24</td><td>33</td><td>115.630</td><td>7.830</td><td>34.583</td><td>3.344</td><td>5.959</td><td>1.314</td></tr><tr><td>24</td><td>35</td><td>52.110</td><td>10.082</td><td>15.990</td><td>3... |
ab30d3bb6858ca583321dd08f72823559c562b2b76c14aec9af9f5a1954a491c.png | simple | <table><tr><td></td><td>%</td><td>Search Meaning (50.6 ± 25.9)</td><td>Message Disease (70.4 ± 20.9)</td><td>Trust Guidance (70.0 ± 26.5)</td><td>Support External (59.0 ± 23.9)</td><td>Support Internal (62.3 ± 24.3)</td></tr><tr><td>sex</td><td></td><td>**</td><td>**</td><td>*</td><td>**</td><t... | <table><tr><td></td><td>%</td><td>Search Meaning (50.6 ± 25.9)</td><td>Message Disease (70.4 ± 20.9)</td><td>Trust Guidance (70.0 ± 26.5)</td><td>Support External (59.0 ± 23.9)</td><td>Support Internal (62.3 ± 24.3)</td></tr><tr><td>sex</td><td></td><td>**</td><td>**</td><td>*</td><td>**</td><td>*</td></tr><tr><td>fema... | <table><tr><td></td><td>%</td><td>Search Meaning (50.6 ± 25.9)</td><td>Message Disease (70.4 ± 20.9)</td><td>Trust Guidance (70.0 ± 26.5)</td><td>Support External (59.0 ± 23.9)</td><td>Support Internal (62.3 ± 24.3)</td></tr><tr><td>Acute diseases</td><td></td><td>7 ± 26.4</td><td>27.1</td><td>76.4 ± 30.6</td><td>6 ± 2... |
e53590bd9ac702a095f345455af7cdd10bac6c8b7b1ecf9976d909e3dbce591a.png | complex | <table><tr><td>WHO region</td><td>One registration authority</td><td>Registration guidelines</td><td>Require WHOPES recommendations</td><td>WHOPES as sole basis</td></tr><tr><td>Africa</td><td></td><td>82 (14/17)</td><td></td><td>45 (13/29)</td><td></td><td>79 (23/29)</td><td></td><td>48 (11/23)</td></tr><tr><td>Americ... | <table><tr><td>WHO region</td><td>One registration authority</td><td>Registration guidelines</td><td>Require WHOPES recommendations</td><td>WHOPES as sole basis</td><td colspan="4"></td></tr><tr><td>Africa</td><td></td><td>82 (14/17)</td><td></td><td>45 (13/29)</td><td></td><td>79 (23/29)</td><td></td><td>48 (11/23)</t... | <table><tr><td>WHO region</td><td>One registration authority</td><td>Registration guidelines</td><td>Require WHOPES recommendations</td><td>WHOPES as sole basis</td><td colspan="4"></td></tr><tr><td>Americas</td><td></td><td>71 (12/17)</td><td></td><td>73 (19/26)</td><td></td><td>60 (15/25)</td><td></td><td>13 (2/15)</... |
7628c3fb13d7ff8d14120846d8a1be34a2a04e9e748130f38852f583a95997cc.png | simple | <table><tr><td>Locus</td><td>Observed, bp</td><td><i>N<sub>a</sub></i></td><td>Fluorescence</td></tr><tr><td>M_fav4</td><td>375-391</td><td>5</td><td>FAM</td></tr><tr><td>maMS2-5</td><td>280-328</td><td>20</td><td>FAM</td></tr><tr><td>maMS8</td><td>197-203</td><td>3</td><td>FAM</td></tr><tr><td>M_fav6</td><td>387-429</... | <table><tr><td>Locus</td><td>Observed, bp</td><td>Na</td><td>Fluorescence</td></tr></table> | <table><tr><td>M_fav4</td><td>375-391</td><td>5</td><td>FAM</td></tr><tr><td>maMS2-5</td><td>280-328</td><td>20</td><td>FAM</td></tr><tr><td>maMS8</td><td>197-203</td><td>3</td><td>FAM</td></tr><tr><td>M_fav6</td><td>387-429</td><td>11</td><td>HEX</td></tr><tr><td>M_fav7</td><td>453-498</td><td>9</td><td>HEX</td></tr><... |
64d7616afc6259992bd149910f1887bd97e2a8a114f9abdd890e070287832ba5.png | complex | <table><tr><td></td><td></td><td>Nevi</td><td>Primary melanomas</td><td>Metastases</td><td><i>p</i>-values</td><td>AUC [95 % C.I.]</td></tr><tr><td>Ki-67 index</td><td>Mean [95%C.I.]</td><td>1.7 % [1.3–2.1]</td><td>21.7 % [18.9–24.3]</td><td>29.9 % [24.9–35]</td><td><i>p</i> < 0.001</td><td>- nevi ... | <table><tr><td></td><td></td><td>Nevi</td><td>Primary melanomas</td><td>Metastases</td><td>p-values</td><td>AUC [95 % C.I.]</td></tr><tr><td>Ki-67 index</td><td>Mean [95%C.I.]</td><td>1.7 % [1.3–2.1]</td><td>21.7 % [18.9–24.3]</td><td>29.9 % [24.9–35]</td><td>p < 0.001</td><td>- nevi vs primary melanomas : 0.959 [0.925... | <table><tr><td rowspan="2">p16-Ki67-HMB45 combined score</td><td>Score 8:</td><td>1.4 %</td><td>12.8 %</td><td rowspan="2">N.A.</td><td rowspan="2">-</td><td rowspan="2">0.987 [0.963–0.997]</td></tr><tr><td>Score 9:</td><td>0 %</td><td>15.4 %</td></tr></table> |
0c4f7189a1e58f422442c0d267c26e931da7120aff84bea6c3fa53a8de544d09.png | simple | <table><tr><td>Variables</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td></tr><tr><td>Total risk score</td><td>–</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>... | <table><tr><td>Variables</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td></tr><tr><td>Total risk score</td><td>–</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><... | <table><tr><td>Variables</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td></tr><tr><td>Fulfilment</td><td>.07</td><td>− .10</td><td>.09</td><td>− .37**</td><td>.28**</td><td>.40**</td><td>.20*</td><td>.19</td>... |
7ab13bf36720d0316024f08a2a376610c8f6408e1c28a5532c84afbf717540f3.png | complex | <table><tr><td colspan="3">Sample activities of social skills training (for children)</td></tr><tr><td>Session number</td><td>Session topics</td><td>Sample activities<sup>†</sup></td></tr><tr><td>1,14,15,20</td><td>Pragmatic speech skills</td><td>Knowing how to introduce themselves in public, such as vocal volume... | <table><tr><td colspan="3">Sample activities of social skills training (for children)</td></tr><tr><td>Session number</td><td>Session topics</td><td>Sample activities†</td></tr><tr><td>1,14,15,20</td><td>Pragmatic speech skills</td><td>Knowing how to introduce themselves in public, such as vocal volume and the manner o... | <table><tr><td colspan="3">Sample activities of social skills training (for children)</td></tr><tr><td>Session number</td><td>Session topics</td><td>Sample activities†</td></tr><tr><td colspan="3">Outline of mothers’ program</td></tr><tr><td>Session number</td><td colspan="2">Session topics</td></tr><tr><td>1</td><td c... |
6d5e44444ca22fde9401656f0cda76f53c2ab613b23a2e4f1d5998ebc31f9fee.png | complex | <table><tr><td>Factors</td><td><i>P-</i>value</td><td>Odds ratio</td><td colspan="2">95% CI of odds ratio</td><td>Observed power</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td><td></td></tr><tr><td>Age ≧50 yr</td><td>0.221</td><td>1.784</td><td>0.705</td><td>4.510</td><td>0.261</td></tr><tr><... | <table><tr><td>Factors</td><td>P-value</td><td>Odds ratio</td><td colspan="2">95% CI of odds ratio</td><td>Observed power</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td><td></td></tr><tr><td>Age ≧50 yr</td><td>0.221</td><td>1.784</td><td>0.705</td><td>4.510</td><td>0.261</td></tr></table> | <table><tr><td>Factors</td><td>P-value</td><td>Odds ratio</td><td colspan="2">95% CI of odds ratio</td><td>Observed power</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td><td></td></tr><tr><td>RAI (+)</td><td>0.046</td><td>2.601</td><td>1.015</td><td>6.664</td><td>0.371</td></tr><tr><td>ACTH ≧5 pg/mL... |
2c0fc0d3613a36f05be9151e4727617f0c945dd93ba35a3466cd9069c82d18c5.png | simple | <table><tr><td>AIN-93M</td><td>Standard diet (w/w)</td><td>High fat-fructose diet (w/w)</td></tr><tr><td>Corn starch</td><td>46%</td><td>46%</td></tr><tr><td>Dextrin</td><td>15.5%</td><td>15.5%</td></tr><tr><td>Casein vitamin free</td><td>14%</td><td>14%</td></tr><tr><td>Sucrose</td><td>10%</td><td>28%</td></tr><tr><td... | <table><tr><td>AIN-93M</td><td>Standard diet (w/w)</td><td>High fat-fructose diet (w/w)</td></tr><tr><td>Corn starch</td><td>46%</td><td>46%</td></tr><tr><td>Dextrin</td><td>15.5%</td><td>15.5%</td></tr><tr><td>Casein vitamin free</td><td>14%</td><td>14%</td></tr><tr><td>Sucrose</td><td>10%</td><td>28%</td></tr><tr><td... | <table><tr><td>AIN-93M</td><td>Standard diet (w/w)</td><td>High fat-fructose diet (w/w)</td></tr><tr><td>AIN 93 vitamin mix</td><td>1%</td><td>1%</td></tr><tr><td>Choline bitartrate</td><td>0.25%</td><td>0.25%</td></tr><tr><td>L-Cystine</td><td>0.18%</td><td>0.18%</td></tr><tr><td>t-Butylhydroquinone</td><td>0.0008%</t... |
ee07bb6df6d803fffde2770a71849fe16a4ace7dae231b81ce476746ed1c37ff.png | complex | <table><tr><td rowspan="2">miRNAs</td><td colspan="3">IPMN</td><td colspan="3">PDAC</td><td rowspan="2">p-value</td></tr><tr><td>Mean</td><td colspan="2">Quartiles</td><td>Mean</td><td colspan="2">Quartiles</td></tr><tr><td>miR-16</td><td>0.063</td><td>0.011</td><td>0.140</td><td>0.157</td><td>0.081</td><td>0.272</td><... | <table><tr><td rowspan="2">miRNAs</td><td colspan="3">IPMN</td><td colspan="3">PDAC</td><td rowspan="2">p-value</td></tr><tr><td>Mean</td><td colspan="2">Quartiles</td><td>Mean</td><td colspan="2">Quartiles</td></tr><tr><td>miR-16</td><td>0.063</td><td>0.011</td><td>0.140</td><td>0.157</td><td>0.081</td><td>0.272</td><... | <table><tr><td rowspan="2">miRNAs</td><td colspan="3">IPMN</td><td colspan="3">PDAC</td><td rowspan="2">p-value</td></tr><tr><td>Mean</td><td colspan="2">Quartiles</td><td>Mean</td><td colspan="2">Quartiles</td></tr><tr><td>181a</td><td></td><td>001</td><td>30</td><td>.073</td><td>018</td><td>.182</td><td></td></tr><tr... |
c2219618814bfa1268f90b01cf214d780285016f816093f4fa21ced7457ad2b0.png | simple | <table><tr><td>Reference</td><td>Year</td><td>Age (years)</td><td>Sex</td><td>Chief Clinical presentation</td><td>Site</td><td>Size (mm)</td><td>Operation</td><td>Follow up (months)</td></tr><tr><td>Inai et al. [16]</td><td>1989</td><td>17</td><td>Male</td><td>Hematoemesis</td><td>Papilla of Vater</td><td>20</td><td>PD... | <table><tr><td>Reference</td><td>Year</td><td>Age (years)</td><td>Sex</td><td>Chief Clinical presentation</td><td>Site</td><td>Size (mm)</td><td>Operation</td></tr><tr><td>Inai et al. [16]</td><td>1989</td><td>17</td><td>Male</td><td>Hematoemesis</td><td>Papilla of Vater</td><td>20</td><td>PD</td></tr><tr><td>Hashimoto... | <table><tr><td>Follow up (months)</td></tr><tr><td>NED 32</td></tr><tr><td>NED 14</td></tr><tr><td>NED 24</td></tr><tr><td>NED 19</td></tr><tr><td>NED 9</td></tr><tr><td>NED 44</td></tr><tr><td>NED 12</td></tr><tr><td>NR</td></tr><tr><td>NR</td></tr><tr><td>NED 6</td></tr></table> |
fd443580c0042494de8ae66e4ec04743a07bf394f27de0640b9c3c9ec93fe18b.png | simple | <table><tr><td>Parameter</td><td>Estimate</td><td>SE</td><td>95% CI</td><td>P</td><td>OR</td></tr><tr><td>Intercept</td><td>3.2</td><td>0.8</td><td>1.6 to 4.9</td><td><0.01</td><td></td></tr><tr><td>Number of anastomoses</td><td>-0.30</td><td>0.17</td><td>-0.64 to 0.05</td><td>0.09</td><td>0.74</td></tr><tr><td>Oper... | <table><tr><td>Parameter</td><td>Estimate</td><td>SE</td><td>95% CI</td><td>P</td><td>OR</td></tr><tr><td>Intercept</td><td>3.2</td><td>0.8</td><td>1.6 to 4.9</td><td><0.01</td><td></td></tr></table> | <table><tr><td>Parameter</td><td>Estimate</td><td>SE</td><td>95% CI</td><td>P</td><td>OR</td></tr><tr><td>Number of anastomoses</td><td>-0.30</td><td>0.17</td><td>-0.64 to 0.05</td><td>0.09</td><td>0.74</td></tr><tr><td>Operation time</td><td>-0.003</td><td>0.001</td><td>-0.006 to -0.001</td><td>0.01</td><td>0.997</td>... |
780ca5447bdb49356e6951b790a5a56a5bf1557309bfb44f31eb8593302c67f5.png | simple | <table><tr><td></td><td>1 Set of Medial Branch Blocks (n=28)Median (IQR)or n (%)</td><td>2 Sets of Medial Branch Blocks (n=27)Median (IQR)or n (%)</td><td>P value</td></tr><tr><td>≥50% improvement in function</td><td>13 (46%)</td><td>17 (63%)</td><td>0.22</td></tr><tr><td>Reduction in NRS pain score</td><td>2 (1,... | <table><tr><td></td><td>1 Set of Medial Branch Blocks (n=28)Median (IQR)or n (%)</td><td>2 Sets of Medial Branch Blocks (n=27)Median (IQR)or n (%)</td><td>P value</td></tr><tr><td>≥50% improvement in function</td><td>13 (46%)</td><td>17 (63%)</td><td>0.22</td></tr><tr><td>Reduction in NRS pain score</td><td>2 (1, 5)</t... | <table><tr><td></td><td>1 Set of Medial Branch Blocks (n=28)Median (IQR)or n (%)</td><td>2 Sets of Medial Branch Blocks (n=27)Median (IQR)or n (%)</td><td>P value</td></tr><tr><td>Change in MQS III score</td><td>2.7(0, 9.6)</td><td>3.4 (0, 11.6)</td><td>0.35</td></tr></table> |
12c0c3f7b81a8b55bd4f31b4e964a5a085ffe7c8aaf9e54768be3f9e166016db.png | complex | <table><tr><td>FPI-6</td><td>Side</td><td>10 years8%Mean ± SD(CI)</td><td>11 years22%Mean ± SD(CI)</td><td>12 years26%Mean ± SD(CI)</td><td>13 years25%Mean ± SD(CI)</td><td>14 years19%Mean ± SD(CI)</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Total score</td><td>R</td><td>2.74 ± 2.2... | <table><tr><td>FPI-</td><td>Si</td><td>10 years8%Me</td><td>11</td><td>12 yea</td><td>13 years25%Mean ± SD(CI)</td><td></td><td>p-valu</td></tr></table> | <table><tr><td>6</td><td>de</td><td>an ± SD(CI)</td><td> years22%Mean ± SD(CI)</td><td>rs26%Mean ± SD(CI)</td><td></td><td>14 years19%Mean ± SD(CI)</td><td>e</td></tr><tr><td rowspan="2">Total score</td><td>R</td><td>2.74 ± 2.22(4.18; 0.26)</td><td>3.91 ± 2.63(4,59; 0.67)</td><td>3.01 ± 2.77(4.73; 0.81)</td><td>2.58 ± ... |
fc834f80287b8c5f2feb14dd546bc7143247feacc1b1db627e7f10421494a229.png | complex | <table><tr><td></td><td>Bias 2–1</td><td>Bias 3–2</td><td>SD 2–1</td><td>SD 3–2</td><td>Δ Bias</td><td>Δ SD</td><td>Bias 2–1</td><td>Bias 3–2</td><td>SD 2–1</td><td>SD 3–2</td><td>Δ Bias</td><td>Δ SD</td></tr><tr><td></td><td colspan="6">Expert 1</td><... | <table><tr><td></td><td>Bias 2–1</td><td>Bias 3–2</td><td>SD 2–1</td><td>SD 3–2</td><td>Δ Bias</td><td>Δ SD</td><td>Bias 2–1</td><td>Bias 3–2</td><td>SD 2–1</td><td>SD 3–2</td><td>Δ Bias</td><td>Δ SD</td></tr><tr><td></td><td colspan="6">Expert 1</td><td colspan="6">Expert 2</td></tr><tr><td>R-TFA</td><td>1</td><td>0</... | <table><tr><td>L-TTA</td><td>2</td><td>0</td><td>8.76</td><td>3.22</td><td>−2</td><td>−5.54</td><td>1</td><td>0</td><td>4.64</td><td>4.20</td><td>−1</td><td>−0.44</td></tr><tr><td>R-FAA</td><td>0</td><td>0</td><td>4.80</td><td>2.82</td><td>0</td><td>−1.98</td><td>0</td><td>1</td><td>4.63</td><td>4.92</td><td>1</td><td>... |
57b99f6641c4ee69620552f55421e30353156284ea757fa77541eaf38bee4033.png | simple | <table><tr><td>Location</td><td>Time period (ms)</td><td>Location (<i>y,z</i>)</td><td><i>Z</i><sub>obs</sub></td><td><i>Z</i><sub>crit</sub></td></tr><tr><td>Study</td></tr><tr><td>Left STS</td><td>383–409</td><td>(-53, 4)</td><td>2.636</td><td>2.50</td></tr><tr><td>Right STS</td><td>588–614</td><td>(-58, ... | <table><tr><td>Location</td><td>Time period (ms)</td><td>Location (y,z)</td><td>Zobs</td><td>Zcrit</td></tr><tr><td>Study</td><td colspan="4"></td></tr><tr><td>Left STS</td><td>383–409</td><td>(-53, 4)</td><td>2.636</td><td>2.50</td></tr><tr><td>Right STS</td><td>588–614</td><td>(-58, 23)</td><td>2.674</td><td>2.57</td... | <table><tr><td>PFC</td><td></td><td>4)</td><td>65</td><td>2.63</td></tr><tr><td></td><td>1561</td><td>(42, 34)</td><td>3.026</td><td>2.91</td></tr><tr><td>Scene preview – all trails</td><td colspan="4"></td></tr><tr><td>Left STS</td><td>486–511</td><td>(-63, 7)</td><td>2.387</td><td>2.32</td></tr><tr><td></td><td>716–7... |
c012bdd7b3d95fe3f6027377733aa188b7392726ae1013cdaf4cf9b2deb70a5d.png | complex | <table><tr><td>Variables</td><td colspan="3">PE at school*</td><td colspan="3">Leisure PA **</td><td colspan="3">Active commuting**</td><td colspan="3">LPA***</td></tr><tr><td> </td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% C... | <table><tr><td>Variables</td><td colspan="3">PE at school*</td><td colspan="3">Leisure PA **</td><td colspan="3">Active commuting**</td><td colspan="3">LPA***</td></tr><tr><td></td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% CI</td><td>%</td><td>PR</td><td>95% CI... | <table><tr><td>Active</td><td>48.9</td><td>1.33</td><td>1.22-1.45</td><td>96.8</td><td>1.66</td><td>1.65-1.67</td><td>74.9</td><td>1.30</td><td>1.28-1.33</td><td>-</td><td>-</td><td>-</td></tr><tr><td colspan="3">Sedentary behavior</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td... |
2554a9f505e3f53309e8b18dac6c3c1cf2dbec58c5782cb789878c660572dd4d.png | simple | <table><tr><td></td><td>Phase</td><td>Metric</td><td>Expert</td><td>Novice</td></tr><tr><td>LSA</td><td>Descending aorta</td><td>Median force (N)</td><td>0.03</td><td>0.07</td></tr><tr><td></td><td>Arch vessel</td><td>FIT (N s)</td><td>0.63</td><td>1.47</td></tr><tr><td>LCCA</td><td>Descending aorta</td><td>Median forc... | <table><tr><td></td><td>Phase</td><td>Metric</td><td>Expert</td><td>Novice</td></tr><tr><td>LSA</td><td>Descending aorta</td><td>Median force (N)</td><td>0.03</td><td>0.07</td></tr><tr><td></td><td>Arch vessel</td><td>FIT (N s)</td><td>0.63</td><td>1.47</td></tr><tr><td>LCCA</td><td>Descending aorta</td><td>Median forc... | <table><tr><td></td><td>Arch vessel</td><td>Mean force (N)</td><td>0.11*</td><td>0.39</td></tr><tr><td></td><td></td><td>Median force (N)</td><td>0.10*</td><td>0.20</td></tr><tr><td></td><td></td><td>Max. force (N)</td><td>0.54*</td><td>1.75</td></tr><tr><td></td><td></td><td>FIT (N s)</td><td>1.71*</td><td>9.11</td></... |
5d7cdb0d11a3df16bf2d7d66b93149c0240d4cfe83ca588daf42aad9570ba7c7.png | simple | <table><tr><td>Genotype groups</td><td>BIS scale</td><td>BAS drive</td><td>BAS fun seeking</td><td>BAS reward responsiveness</td><td>BIS11 attentional impulsiveness</td><td>BIS11 motor impulsiveness</td><td>BIS11 non-planning impulsiveness</td></tr><tr><td>LL</td><td>3.01 ± 0.12</td><td>3.12 ± 0.09</td><td>3.... | <table><tr><td>Genotype groups</td><td>BIS scale</td><td>BAS drive</td><td>BAS fun seeking</td><td>BAS reward responsiveness</td><td>BIS11 attentional impulsiveness</td><td>BIS11 motor impulsiveness</td><td>BIS11 non-planning impulsiveness</td></tr></table> | <table><tr><td>LL</td><td>3.01 ± 0.12</td><td>3.12 ± 0.09</td><td>3.11 ± 0.1</td><td>3.41 ± 0.09</td><td>16.4 ± 0.6</td><td>23.5 ± 0.8</td><td>22.18 ± 1</td></tr><tr><td>HH</td><td>2.88 ± 0.12</td><td>3.03 ± 0.1</td><td>2.95 ± 0.1</td><td>3.30 ± 0.09</td><td>16.5 ± 0.6</td><td>23.9 ± 0.8</td><td>23.8 ± 1</td></tr></tab... |
af771b9ab2f7f78e6e57adf47c811d2d4d0514e5edb4ee2e7f39f7a7c5f7498d.png | simple | <table><tr><td>Target gene (rat)</td><td>Primer sequence</td><td>Predicted length (bp)</td></tr><tr><td><i>β</i>-catenin</td><td>F:CTCCCCTGACAGAGTTGCT R:ATGTCCAGTCCGAGATCAGC</td><td>187</td></tr><tr><td>CCND1</td><td>F:GCGTACCCTGACACCAATCT R:CTCTTCGCACTTCTGCTCCT</td><td>180</td></tr><tr><td>c-Myc</td><td>F:GCTCCTC... | <table><tr><td>Target gene (rat)</td><td>Primer sequence</td><td>Predicted length (bp)</td></tr><tr><td>β-catenin</td><td>F:CTCCCCTGACAGAGTTGCT R:ATGTCCAGTCCGAGATCAGC</td><td>187</td></tr><tr><td>CCND1</td><td>F:GCGTACCCTGACACCAATCT R:CTCTTCGCACTTCTGCTCCT</td><td>180</td></tr></table> | <table><tr><td>c-Myc</td><td>F:GCTCCTCGCGTTATTTGAAG R:TTCTCTTCCTCGTCGCAGAT</td><td>152</td></tr><tr><td>GSK-3β</td><td>F:TCCGATTGCGGTATTTCTT R:TCACAGGGAGTGTCTGCTT</td><td>138</td></tr><tr><td>Bcl-2</td><td>F:AGTACCTGAACCGGCATCTG R:CAGGTATGCACCCAGAGTGA</td><td>173</td></tr><tr><td>Bax</td><td>F:CGAGCTGATCAGAACCATCA R:CT... |
91d14c65d6aa183433a765c53fb99bedf783987037f0dcb197891fdb4ab4f666.png | complex | <table><tr><td rowspan="3"></td><td>Unadjusted model</td><td>Adjusted model 1</td><td>Adjusted model 2 recoded e-cig variable</td><td>Adjusted model 3 imputed model m = 20</td></tr><tr><td rowspan="2">OR (99 % CI)</td><td>OR (99 % CI)</td><td>OR (99 % CI)</td><td>OR (99 % CI)</td></tr><tr><td><i>n</i> = 2824</td><td><i... | <table><tr><td rowspan="3"></td><td>Unadjusted model</td><td>Adjusted model 1</td><td>Adjusted model 2 recoded e-cig variable</td><td>Adjusted model 3 imputed model m = 20</td></tr><tr><td rowspan="2">OR (99 % CI)</td><td>OR (99 % CI)</td><td>OR (99 % CI)</td><td>OR (99 % CI)</td></tr><tr><td>n = 2824</td><td>n = 3363<... | <table><tr><td>n-white</td><td></td><td>to 1.61)</td><td> 1.10)</td><td> (0.47 to 1.53)</td></tr><tr><td>Age</td><td></td><td>1.23 (1.00 to 1.52)</td><td>1.23 (1.04 to 1.46)</td><td>1.24 (1.07 to 1.43)</td></tr><tr><td>FAS low</td><td></td><td>1</td><td>1</td><td>1</td></tr><tr><td>FAS medium</td><td></td><td>1.46 (0.9... |
1e008fc03bb921399ca0b3c1a63cebaf1bc63e3c880f620efe16be1160cfc186.png | complex | <table><tr><td>Tissue</td><td colspan="2">Pooled mean (SD)</td><td>Mean difference (95% CI)</td></tr><tr><td> </td><td>64-row</td><td>128-row</td><td> </td></tr><tr><td>Lung</td><td>93.90 (1.89)</td><td>93.30 (2.03)</td><td>0.60 (-0.66 to 1.86)</td></tr><tr><td>Bone</td><td>93.28 (2.32)</td><td>92.15 (3.63)</td><td>1.1... | <table><tr><td>Tissue</td><td colspan="2">Pooled mean (SD)</td><td>Mean difference (95% CI)</td></tr><tr><td></td><td>64-row</td><td>128-row</td><td></td></tr></table> | <table><tr><td>Lung</td><td>93.90 (1.89)</td><td>93.30 (2.03)</td><td>0.60 (-0.66 to 1.86)</td></tr><tr><td>Bone</td><td>93.28 (2.32)</td><td>92.15 (3.63)</td><td>1.13 (-0.82 to 3.08)</td></tr><tr><td>Vessel</td><td>91.60 (3.31)</td><td>89.90 (4.84)</td><td>1.70 (-0.95 to 4.35)</td></tr><tr><td>Organ</td><td>89.60 (3.9... |
70cdf0bc1ef1460bcadab1521135ae22cabd14583a8152cbb393437138ffc8ec.png | simple | <table><tr><td>Index</td><td>Abbreviation</td><td>Threshold</td><td>Reference</td></tr><tr><td>Chi-square</td><td>χ<sup>2</sup></td><td>>0.05</td><td>[51]</td></tr><tr><td>Normed Comparative Fit</td><td>CFI</td><td>≥0.90</td><td>[53]</td></tr><tr><td>Goodness-of-Fit Index</td><td>GFI</td><td>≥0.90</... | <table><tr><td>Index</td><td>Abbreviation</td></tr><tr><td>Chi-square</td><td>χ2</td></tr><tr><td>Normed Comparative Fit</td><td>CFI</td></tr><tr><td>Goodness-of-Fit Index</td><td>GFI</td></tr><tr><td>Adjusted-Goodness-of-Fit Index</td><td>AGFI</td></tr><tr><td>Chis-square/Degrees of Freedom</td><td>(χ2)/df</td></tr><t... | <table><tr><td>Threshold</td><td>Reference</td></tr><tr><td>>0.05</td><td>[51]</td></tr><tr><td>≥0.90</td><td>[53]</td></tr><tr><td>≥0.90</td><td>[54]</td></tr><tr><td>≥0.90</td><td>[54]</td></tr><tr><td><2</td><td>[50,55]</td></tr><tr><td><0.05 or <0.08</td><td>[56]</td></tr></table> |
277212991e11282cf48b2caaa072e579f8181072cb7816aca36e162411d937eb.png | complex | <table><tr><td></td><td>Stimulus</td><td>40 ml VS 80 ml</td><td>40 ml VS 120 ml</td><td>80 ml VS 120 ml</td></tr><tr><td rowspan="2">IBS</td><td><i>P</i> value</td><td>0.377</td><td>0.039</td><td>0.002</td></tr><tr><td>95%CI</td><td>−0.192–0.498</td><td>−0.614–0.016</td><td>−0.752–0.... | <table><tr><td></td><td>Stimulus</td><td>40 ml VS 80 ml</td><td>40 ml VS 120 ml</td><td>80 ml VS 120 ml</td></tr><tr><td>IBS</td><td>P value</td><td>0.377</td><td>0.039</td><td>0.002</td></tr></table> | <table><tr><td>IBS</td><td>95%CI</td><td>−0.192–0.498</td><td>−0.614–0.016</td><td>−0.752–0.185</td></tr><tr><td rowspan="2">Controls</td><td>P value</td><td>0.684</td><td>0.876</td><td>0.549</td></tr><tr><td>95%CI</td><td>−0.223–0.149</td><td>−0.215–0.250</td><td>−0.132–0.240</td></tr></table> |
d1df363e3105f3ed037d7083c745561d81c655bd9ba7039803fc5c108cf026b4.png | complex | <table><tr><td></td><td colspan="4">Prevalence (*1000 subjects)</td><td colspan="2">Incidence (*1000 person years)</td></tr><tr><td></td><td colspan="2">31/12/2001</td><td colspan="2">31/12/2004</td><td colspan="2">Mean 2002 – 2004</td></tr><tr><td></td><td>males</td><td>females</td><td>males</td><td>females</td>... | <table><tr><td></td><td colspan="4">Prevalence (*1000 subjects)</td><td colspan="2">Incidence (*1000 person years)</td></tr><tr><td></td><td colspan="2">31/12/2001</td><td colspan="2">31/12/2004</td><td colspan="2">Mean 2002 – 2004</td></tr><tr><td></td><td>males</td><td>females</td><td>males</td><td>females</td><td>ma... | <table><tr><td></td><td colspan="4">Prevalence (*1000 subjects)</td><td colspan="2">Incidence (*1000 person years)</td></tr><tr><td></td><td>5.3–5.9</td><td>4–4.5</td><td>5.2–5.8</td><td>4.7–5.3</td><td>1.2–1.4</td><td>1–1.2</td></tr><tr><td>45–54 years</td><td>40.1</td><td>21</td><td>41.2</td><td>19.4</td><td>6.7</td>... |
e34e289b145b06848a0f26d94653f414ac85fe805d0ada9d081da4338e8f67b9.png | simple | <table><tr><td>Year (GC)</td><td>2005</td><td>2006</td><td>2007*</td><td>2008*</td><td>Average</td></tr><tr><td>Total out-patient malaria cases/1000</td><td>27.098</td><td>22.400</td><td>19.928</td><td>23.950</td><td>23.388</td></tr><tr><td>Malaria in-patients/10,000</td><td>10.670</td><td>6.343</td><td>3.976</td><td>4... | <table><tr><td>Year (GC)</td><td>2005</td><td>2006</td><td>2007*</td><td>2008*</td><td>Average</td></tr><tr><td>Total out-patient malaria cases/1000</td><td>27.098</td><td>22.400</td><td>19.928</td><td>23.950</td><td>23.388</td></tr><tr><td>Malaria in-patients/10,000</td><td>10.670</td><td>6.343</td><td>3.976</td><td>4... | <table><tr><td>Malaria in pregnancy out-patients/1,000</td><td>0.345</td><td>0.309</td><td>0.260</td><td>0.319</td><td>0.309</td></tr><tr><td>Malaria in pregnancy in-patients/10,000</td><td>0.264</td><td>0.169</td><td>0.115</td><td>0.161</td><td>0.179</td></tr><tr><td>Malaria in pregnancy deaths/100,000</td><td>0.096</... |
dfa16a55bfb914f600b0900359b19b8a4e1f27ba885a0dd0b5d0159d20f0dbc5.png | complex | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Duodenum</td><td colspan="2">Jejunum</td><td colspan="2">Ileum</td></tr><tr><td>d 5</td><td>d 11</td><td>d 5</td><td>d 11</td><td>d 5</td><td>d 11</td></tr><tr><td>PS</td><td>2.5 (2, 5)</td><td>3 (1, 6)</td><td>2.5 (1, 4)</td><td>5 (2, 9)</td><td>3 (1, 5)</td><td... | <table><tr><td rowspan="2">Treatment</td><td colspan="2">Duodenum</td><td colspan="2">Jejunum</td><td colspan="2">Ileum</td></tr><tr><td>d 5</td><td>d 11</td><td>d 5</td><td>d 11</td><td>d 5</td><td>d 11</td></tr><tr><td>PS</td><td>2.5 (2, 5)</td><td>3 (1, 6)</td><td>2.5 (1, 4)</td><td>5 (2, 9)</td><td>3 (1, 5)</td><td... | <table><tr><td>MA</td><td>3 (2, 5)</td><td>2.5 (1, 6)</td><td>2.5 (2, 4)</td><td>3 (1, 8)</td><td>1 (1, 3)</td><td>1 (1, 4)</td></tr></table> |
0a0c557cb29491bacbb95caa11fd41009f463cc7e897632dd131dbb7a146a82a.png | simple | <table><tr><td>Colorectal</td><td>36 (67.9%)</td></tr><tr><td>Gynecologic</td><td>6 (11.3%)</td></tr><tr><td>Urologic</td><td>5 (9.4%)</td></tr><tr><td>Leimyosarcoma</td><td>3 (5.7%)</td></tr><tr><td>Anal</td><td>2 (3.8%)</td></tr><tr><td>Benign</td><td>1 (1.9%)</td></tr></table> | <table><tr><td>Colo</td><td>36 (67.9%)</td></tr></table> | <table><tr><td>rectal</td><td></td></tr><tr><td>Gynecologic</td><td>6 (11.3%)</td></tr><tr><td>Urologic</td><td>5 (9.4%)</td></tr><tr><td>Leimyosarcoma</td><td>3 (5.7%)</td></tr><tr><td>Anal</td><td>2 (3.8%)</td></tr><tr><td>Benign</td><td>1 (1.9%)</td></tr></table> |
3ff588293748435e12e12e8b6b855b2bc993b9a10480f858cfa8f377f7c7311c.png | simple | <table><tr><td>ID</td><td>BDNF</td><td>Pain</td><td>Sleep quality</td></tr><tr><td>3</td><td>Val/Val</td><td>Healthy Control</td><td>Poor quality</td></tr><tr><td>6</td><td>Val/Val</td><td>Healthy Control</td><td>Good quality</td></tr><tr><td>11</td><td>Val/Val</td><td>CAP</td><td>Good quality</td></tr><tr><td>16</td><... | <table><tr><td>ID</td><td>BDNF</td></tr><tr><td>3</td><td>Val/Val</td></tr><tr><td>6</td><td>Val/Val</td></tr><tr><td>11</td><td>Val/Val</td></tr><tr><td>16</td><td>Val/Val</td></tr><tr><td>22</td><td>Val/Val</td></tr><tr><td>25</td><td>Val/Val</td></tr><tr><td>35</td><td>Val/Val</td></tr><tr><td>36</td><td>Val/Val</td... | <table><tr><td>Pain</td><td>Sleep quality</td></tr><tr><td>Healthy Control</td><td>Poor quality</td></tr><tr><td>Healthy Control</td><td>Good quality</td></tr><tr><td>CAP</td><td>Good quality</td></tr><tr><td>CAP</td><td>Poor quality</td></tr><tr><td>Healthy Control</td><td>Good quality</td></tr><tr><td>Healthy Control... |
483bf942b7e7e7f73ba54ad7b47cfca9006706557cb0b4f075a40246d352918d.png | simple | <table><tr><td>GEO ID</td><td>Symbol Color</td><td>Medium</td><td>n</td><td>Reference</td></tr><tr><td>GSE6741</td><td>● 20% O<sub>2 </sub>- light green● 2% O<sub>2 </sub>- gold● 0.4% O<sub>2 </sub>- red● 0% O<sub>2 </sub>+ nitrate - dark green</td><td>minimal amino acids 37°C, sparged and ... | <table><tr><td>GEO ID</td><td>Symbol Color</td><td>Medium</td><td>n</td><td>Reference</td></tr><tr><td>GSE6741</td><td>● 20% O2 - light green● 2% O2 - gold● 0.4% O2 - red● 0% O2 + nitrate - dark green</td><td>minimal amino acids 37°C, sparged and stirred exponential phase, OD ~ 0.08</td><td>2</td><td>[15]</td></tr><tr>... | <table><tr><td>GEO ID</td><td>Symbol Color</td><td>Medium</td><td>n</td><td>Reference</td></tr><tr><td>GSE8408</td><td>● control - dark gray</td><td>minimal succinate and non-sulfur containing amino acids, 30°C, shaken, OD ~ 0.2</td><td>3</td><td>[21]</td></tr></table> |
6e68b79facc8b78528b27ba1b8e8f6faafcb7de647269ea5d5cc07418b79a811.png | simple | <table><tr><td>Group</td><td><i>Treatment</i></td><td>Percentage of Double-strand DNA</td><td>Number of single-strand breaks/DNA fragment</td><td>Inhibition (%)</td></tr><tr><td>A</td><td>Normal</td><td>93.56</td><td>0.07 ± 0.02<sup>a</sup></td><td></td></tr><tr><td>B</td><td>DENA Control</td><td>31.68</td><td>1.3... | <table><tr><td>Group</td><td>Treatment</td><td>Percentage of Double-strand DNA</td><td>Number of single-strand breaks/DNA fragment</td><td>Inhibition (%)</td></tr><tr><td>A</td><td>Normal</td><td>93.56</td><td>0.07 ± 0.02a</td><td></td></tr><tr><td>B</td><td>DENA Control</td><td>31.68</td><td>1.32 ± 0.01 b</td><td></td... | <table><tr><td>D</td><td>DENA+BC</td><td>52.87</td><td>0.54 ± 0.04 c</td><td>59.09</td></tr><tr><td>E</td><td>DENA+V+BC</td><td>64.73</td><td>0.48 ± 0.023 d</td><td>63.6</td></tr></table> |
0e5df84ad68e0cf4ec1278f954b45f0033802d36d7599e37e6a9eba340ad9a6a.png | simple | <table><tr><td>Organ</td><td>Mean</td><td>S.D</td><td>Med</td><td>Min</td><td>Max</td></tr><tr><td>Left wrist</td><td>130.9</td><td>88.83</td><td>106.94</td><td>30.55</td><td>376.01</td></tr><tr><td>Right wrist</td><td>93.65</td><td>82.01</td><td>57.21</td><td>19.72</td><td>385.91</td></tr><tr><td>Thyroid</td><td>40.05... | <table><tr><td>Organ</td><td>Mean</td><td>S.D</td><td>Med</td></tr><tr><td>Left wrist</td><td>130.9</td><td>88.83</td><td>106.94</td></tr><tr><td>Right wrist</td><td>93.65</td><td>82.01</td><td>57.21</td></tr><tr><td>Thyroid</td><td>40.05</td><td>21.65</td><td>32.36</td></tr><tr><td>Eye</td><td>30.15</td><td>15.01</td>... | <table><tr><td>Min</td><td>Max</td></tr><tr><td>30.55</td><td>376.01</td></tr><tr><td>19.72</td><td>385.91</td></tr><tr><td>11.04</td><td>101.00</td></tr><tr><td>10.16</td><td>95.01</td></tr></table> |
c48ba67e5e04ae0bae62712054d889ee62ce3966b0fccebe1e65392ea66c810c.png | simple | <table><tr><td>4B5</td><td>HER2 amplification</td><td>no HER2 amplication</td><td>SP3</td><td>HER2 amplification</td><td>no HER2 amplification</td><td>Herceptest</td><td>HER2 amplification</td><td>no HER2 amplification</td></tr><tr><td>0,1+</td><td>3</td><td>907</td><td>0,1+</td><td>3</td><td>924</td><td>0,1+</td><td>1... | <table><tr><td>4B5</td><td>HER2 amplification</td><td>no HER2 amplication</td><td>SP3</td><td>HER2 amplification</td><td>no HER2 amplification</td><td>Herceptest</td><td>HER2 amplification</td><td>no HER2 amplification</td></tr><tr><td>0,1+</td><td>3</td><td>907</td><td>0,1+</td><td>3</td><td>924</td><td>0,1+</td><td>1... | <table><tr><td>4B5</td><td>HER2 amplification</td><td>no HER2 amplication</td><td>SP3</td><td>HER2 amplification</td><td>no HER2 amplification</td><td>Herceptest</td><td>HER2 amplification</td><td>no HER2 amplification</td></tr><tr><td>2+</td><td>8</td><td>46</td><td>2+</td><td>13</td><td>36</td><td>2+</td><td>11</td><... |
c1c388b5b695ff93a558c1c302417d3d40fad4dba39c11096d636ff6daaeefa4.png | complex | <table><tr><td></td><td colspan="5">Mean (SD) Scores (max. score 5)</td></tr><tr><td>Subscales</td><td>AH</td><td>TH</td><td>AC</td><td>SKMC</td><td>p-value</td></tr><tr><td>Teacher Characteristics (17items)</td><td>3.50 (1.08)</td><td>3.84 (0.93)</td><td>3.86 (1.21)</td><td>4.48 (0.46)</td><td>0.008</td></tr><tr><td>I... | <table><tr><td></td><td>Mean (SD) Scores (max. score 5)</td></tr><tr><td>Subscales</td><td>AH</td></tr><tr><td>Teacher Characteristics (17items)</td><td>3.50 (1.08)</td></tr><tr><td>Involvement in direct patient care (6 items)</td><td>3.26 (1.06)</td></tr><tr><td>Patients (4 items)</td><td>3.44 (1.02)</td></tr><tr><td>... | <table><tr><td colspan="4">Mean (SD) Scores (max. score 5)</td></tr><tr><td>TH</td><td>AC</td><td>SKMC</td><td>p-value</td></tr><tr><td>3.84 (0.93)</td><td>3.86 (1.21)</td><td>4.48 (0.46)</td><td>0.008</td></tr><tr><td>3.85 (1.06)</td><td>3.68 (1.19)</td><td>4.12 (0.51)</td><td>0.03</td></tr><tr><td>3.92 (0.99)</td><td... |
540b2732ad1d46669725e6efdc6c6dd85c66aa937f29810e2f544ca7ebc97a6f.png | complex | <table><tr><td> </td><td colspan="2"><i>MTHFR </i>C677T genotype</td><td> </td><td colspan="2"><i>MTHFR </i>A1298C genotype</td></tr><tr><td> </td><td>ALL group</td><td>Control group</td><td> </td><td>ALL group</td><td>Control group</td></tr><tr><td>CC type</td><td>28 (28.6%)</td><td>29 (31.2%)</td><td>AA type</td><td>... | <table><tr><td></td><td colspan="2">MTHFR C677T genotype</td><td></td><td colspan="2">MTHFR A1298C genotype</td></tr><tr><td></td><td>ALL group</td><td>Control group</td><td></td><td>ALL group</td><td>Control group</td></tr></table> | <table><tr><td>CC type</td><td>28 (28.6%)</td><td>29 (31.2%)</td><td>AA type</td><td>54 (55.1%)</td><td>67 (72.0%)</td></tr><tr><td>CT type</td><td>44 (44.9%)</td><td>49 (52.7%)</td><td>AC type</td><td>42 (42.9%)</td><td>25 (26.9%)</td></tr><tr><td>TT type</td><td>26 (26.5%)</td><td>15 (16.1%)</td><td>CC type</td><td>2... |
be45342b2660055ef9f45c38580858fbdc6ad857bdd3c495e78a828857c037ba.png | simple | <table><tr><td>Task</td><td>NHP mean (<i>SD</i>)</td><td>RHDN+ mean (<i>SD</i>)</td><td>RHDN_Mean (<i>SD</i>)</td><td><i>t</i>-test RHDN+ vs. controls</td><td><i>t</i>-test RHDN_ vs. controls</td><td><i>t</i>-test RHDN+ vs. RHDN+</td></tr><tr><td>Counting</td><td>4 (0)</td><td>3.5 (0.67)</td><td>4 (0)</td><td><i>t</i><... | <table><tr><td>Task</td><td>NHP mean (SD)</td><td>RHDN+ mean (SD)</td><td>RHDN_Mean (SD)</td><td>t-test RHDN+ vs. controls</td><td>t-test RHDN_ vs. controls</td><td>t-test RHDN+ vs. RHDN+</td></tr><tr><td>Counting</td><td>4 (0)</td><td>3.5 (0.67)</td><td>4 (0)</td><td>t(22) = 2.57; p = 0.017</td><td>NA; n.s.</td><td>t(... | <table><tr><td>Task</td><td>NHP mean (SD)</td><td>RHDN+ mean (SD)</td><td>RHDN_Mean (SD)</td><td>t-test RHDN+ vs. controls</td><td>t-test RHDN_ vs. controls</td><td>t-test RHDN+ vs. RHDN+</td></tr><tr><td>Mental one-digit addition</td><td>9.92 (0.29)</td><td>9.25 (0.97)</td><td>9.83 (0.39)</td><td>t(22) = 2.92;p = 0.03... |
7cd89f639e942b287bc176d6366d93c4eb3c38582ada35aaa1f7c295264386bc.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">Kenya</td><td colspan="2">Nagpur, India</td><td colspan="2">Belgaum, India</td><td colspan="2">Total</td></tr><tr><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td></tr><tr><td>Registry deliveries<sup>a</sup>, n</td><td>88... | <table><tr><td rowspan="2"></td><td colspan="2">Kenya</td><td colspan="2">Nagpur, India</td><td colspan="2">Belgaum, India</td><td colspan="2">Total</td></tr><tr><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td><td>Pre</td><td>Post</td></tr></table> | <table><tr><td>Registry deliveriesa, n</td><td>8875</td><td>8394</td><td>9461</td><td>9721</td><td>16,992</td><td>16,715</td><td>35,328</td><td>34,830</td></tr><tr><td colspan="9">Birth location, n (%)</td></tr><tr><td>Hospital</td><td>1203 (13.6)</td><td>1296 (15.4)</td><td>6323 (66.8)</td><td>6995 (72.0)</td><td>12,5... |
0b9d9e3fc6e877ddfe6f535d08e4baebe8b0d279c599df016f300845d1ea63f2.png | simple | <table><tr><td>OTU</td><td>Phylum</td><td>Class</td><td>Oder</td><td>Family</td><td>Genus</td></tr><tr><td>OTU077</td><td>Acidobacteria</td><td>Acidobacteria_Gp3</td><td>incertae_sedis</td><td>incertae_sedis</td><td>Gp3</td></tr><tr><td>OTU136</td><td>Acidobacteria</td><td>Acidobacteria_Gp4</td><td>incertae_sedis</td><... | <table><tr><td>OTU</td><td>Phylum</td><td>Class</td><td>Oder</td><td>Family</td><td>Genus</td></tr><tr><td>OTU077</td><td>Acidobacteria</td><td>Acidobacteria_Gp3</td><td>incertae_sedis</td><td>incertae_sedis</td><td>Gp3</td></tr><tr><td>OTU136</td><td>Acidobacteria</td><td>Acidobacteria_Gp4</td><td>incertae_sedis</td><... | <table><tr><td>OTU033</td><td>Proteobacteria</td><td>Gammaproteobacteria</td><td>Unclassified</td><td>Unclassified</td><td>Unclassified</td></tr><tr><td>OTU102</td><td>Proteobacteria</td><td>Gammaproteobacteria</td><td>Xanthomonadales</td><td>Xanthomonadaceae</td><td>Thermomonas</td></tr><tr><td>OTU040</td><td>Proteoba... |
6c68e17ac1f7959795204a4644852b3c70437631dfe018e34302eef3be9562ad.png | simple | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Target Material</td><td>Ag</td></tr><tr><td>Power</td><td>50 W</td></tr><tr><td>Sputter time</td><td>30 min</td></tr><tr><td>Process stress</td><td>1.8 × 10<sup>−2</sup> torr</td></tr><tr><td>Environment temperature</td><td>27 °C</td></tr></table> | <table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Target Material</td><td>Ag</td></tr><tr><td>Power</td><td>50 W</td></tr></table> | <table><tr><td>Sputter time</td><td>30 min</td></tr><tr><td>Process stress</td><td>1.8 × 10−2 torr</td></tr><tr><td>Environment temperature</td><td>27 °C</td></tr></table> |
6f76a5402d1172b21730f4bba3a44d7f11dd0caf77aff270a3515808b83dc73a.png | simple | <table><tr><td>Compound number</td><td>MW</td><td>RBT</td><td>HBAcc</td><td>HBDon</td><td>PSA</td><td>AlogP</td><td>Cerius2 prediction</td><td>VolSurf prediction</td></tr><tr><td>1</td><td>583</td><td>10</td><td>5</td><td>1</td><td>56</td><td>5.6</td><td>High penetrant (1)</td><td><underline>Medium/Undefined</underline... | <table><tr><td>Compound number</td><td>MW</td><td>RBT</td><td>HBAcc</td><td>HBDon</td><td>PSA</td><td>AlogP</td><td>Cerius2 prediction</td><td>VolSurf prediction</td></tr><tr><td>1</td><td>583</td><td>10</td><td>5</td><td>1</td><td>56</td><td>5.6</td><td>High penetrant (1)</td><td>Medium/Undefined</td></tr><tr><td>2</t... | <table><tr><td>Compound number</td><td>MW</td><td>RBT</td><td>HBAcc</td><td>HBDon</td><td>PSA</td><td>AlogP</td><td>Cerius2 prediction</td><td>VolSurf prediction</td></tr><tr><td>4</td><td>255</td><td>2</td><td>2</td><td>1</td><td>26</td><td>4.4</td><td>Very penetrant (0)</td><td>High permeant</td></tr><tr><td>5</td><t... |
f739e082945ed53977fc829eeb73c1c2b2289d4aeab5bf9518398fd9d474600c.png | simple | <table><tr><td>Plant</td><td>Extract</td><td>DPPH radical scavenging assay %</td><td>Iron chelating assay %</td><td>Inhibition % of glycogen phosphorylase (5mg/ml)</td><td>Brine shrimp lethality (LC <sub>50</sub>)</td></tr><tr><td><i>Acacia Senegal</i></td><td>Ethanolic</td><td>NOT ACTIVE</td><td>NOT ACTIVE</td><td>0</... | <table><tr><td>Plant</td><td>Extract</td></tr><tr><td>Acacia Senegal</td><td>Ethanolic</td></tr><tr><td></td><td>Aqueous</td></tr><tr><td>Ambrosia maritima</td><td>Ethanolic</td></tr><tr><td></td><td>Aqueous</td></tr><tr><td>Ammi visnaga</td><td>Ethanolic</td></tr><tr><td></td><td>Aqueous</td></tr><tr><td>Foeniculum vu... | <table><tr><td>DPPH radical scavenging assay %</td><td>Iron chelating assay %</td><td>Inhibition % of glycogen phosphorylase (5mg/ml)</td><td>Brine shrimp lethality (LC 50)</td></tr><tr><td>NOT ACTIVE</td><td>NOT ACTIVE</td><td>0</td><td>83.8716</td></tr><tr><td>NOT ACTIVE</td><td>NOT ACTIVE</td><td>0</td><td>17.9948</... |
7b34f4d5f41c93102057ffe324e8dd0f9c7cbdf6749f843815bc9c012840fb42.png | complex | <table><tr><td></td><td>OR</td><td colspan="2">95% Confidence Interval</td><td><i>p</i></td></tr><tr><td colspan="5">Incident unplanned pregnancies</td></tr><tr><td>Pregnancy prior to baseline</td><td>1.01</td><td>0.39</td><td>2.64</td><td>0.98</td></tr><tr><td>Age</td><td>0.90</td><td>0.60</td><td>1.35</td><td>0.61</t... | <table><tr><td></td><td>OR</td><td colspan="2">95% Confidence Interval</td><td>p</td></tr></table> | <table><tr><td colspan="5">Incident unplanned pregnancies</td></tr><tr><td>Pregnancy prior to baseline</td><td>1.01</td><td>0.39</td><td>2.64</td><td>0.98</td></tr><tr><td>Age</td><td>0.90</td><td>0.60</td><td>1.35</td><td>0.61</td></tr><tr><td>Relationship duration</td><td>1.00</td><td>0.98</td><td>1.01</td><td>0.58</... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.